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2. ABSTRACT 
Polycyclic aromatic hydrocarbons (PAHs) are a group of persistent, ubiquitous and 
carcinogenic chemicals found in the environment. PAHs can be formed anthropogenically and 
naturally. Dibenzothiophene (DBT) is a sulfur-containing PAH typically used as a model 
chemical to study biodegradation of PAHs and bioremediation. Biostimulation using more 
readily metabolized substrates can increase the biodegradation rate of PAHs, but the molecular 
mechanisms are not well understood. In this thesis, the effects of using glycerol as a co-substrate 
were investigated during DBT biodegradation by Burkholderia sp. C3 with respect to (i) DBT 
biodegradation kinetics, (ii) bacterial growth, (iii) proteome profiling, (iv) secretion of the 
biosurfactant rhamnolipid (RL), (v) RL biosynthesis inhibition, (vi) RL characterization and (vii) 
polyhydroxyalkanoates (PHA) vesicle formation. The results indicated that glycerol enhanced 
DBT biodegradation and supported bacterial growth, a phenomenon known as cometabolism. 
Optimized glycerol to DBT molar ratios increased DBT biodegradation rate constants up to 18-
fold and enhanced DBT cometabolism by 25-30% at day 1 relative to DBT alone. At day 7 DBT 
(0.5 mM or 100 ppm) was completely biodegraded at a 100:1 glycerol to DBT molar ratio. Such 
increases were associated with nearly tripled amounts of RL secreted. RL analysis indicated 
biosynthesis, secretion and relevance of RLs to the enhanced DBT cometabolism. RLs reduced 
the surface tension of cultures with a DBT and glycerol mixture from 60-65 to 48-51 mN/m. RL 
biosynthesis inhibition with 2-bromooctanoic acid at 5 mM decreased DBT biodegradation rate 
comparable to that with DBT alone. Production of PHA vesicles were induced with glycerol and 
inhibited with 2 bromoalkanoic acids. RLs and PHA vesicles shared the same lipid precursor. All 
proteins involved in dTDP-rhamnose sugar precursor and R-3-hydroxydecanoyl-CoA lipid 
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precursor for RL biosynthesis were accumulated under the conditions tested. RhlABC proteins 
mediate the final steps in RL formation. The work presented in this dissertation showed that 
glycerol induces DBT cometabolism at a dose dependent manner over time, which positively 
associates with bacterial growth, PHA lipid granule formation and RL biosynthesis and 
secretion. This is the first description of anabolic pathways involved in RL biosynthesis and 
bromooctanoic acid inhibitory mechanism in a Burkholderia species.  
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5. CHAPTER 1: LITERATURE REVIEW 
5.1.1. Polycyclic Aromatic hydrocarbons (PAHs) and its frequency in the 
environment 
Polycyclic Aromatic hydrocarbons (PAHs) are environmentally persistent, ubiquitous 
and carcinogenic chemicals (1–3) containing two or more fused aromatic rings in a linear, 
angular or clustered arrangement (3). The major sources of PAHs are petrogenic, pyrogenic and 
biogenic (4). Persistence of PAHs and its high frequency in the environment can be attributed to 
the aromatic character of the molecule, which confers an unusual low reactivity and high 
stability (5).  
 
Figure 1. Clar structure of phenanthrene. Only two resonance structures are shown in 
the figure. Aromatic π-sextets are indicated with a circle. The Clar structure is the resonance 
structure with the highest number of aromatic π-sextet. Figure adapted from (5). 
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The aromaticity of a PAH is explained in Clar’s postulation which is an extension of 
4n+2 Hückel’s rule (3, 6). In Clar’s postulation is stated that π-electrons (2pz) are assigned to a 
PAH in order to obtain the largest number of disjoint aromatic π-sextet. A π-sextet contains six 
π-electrons in a benzene ring separated by C-C single bond from the adjacent ring (6). The Clar 
structure of a PAH is the resonance structure that has the highest number of isolated and 
localized aromatic π-sextet with the least number of localized double bonds (Figure 1). This 
structure is less active or kinetically more stable than the rest of the resonance structures. 
Likewise, the π-sextet centers are more aromatic and thus, less reactive than the other rings 
present in the molecule (5, 6).  
 
Table 1. Elemental atom composition of crude oil from Saudi Arabia from (7).  
Component  Fresh Saudi oil (wt%) 
Carbon 84.80 
Hydrogen 13.00 
Sulphur 1.94 
Oxygen <0.50 
Nitrogen 0.10 
Calorific Value (mJ.K
-1
) 44.64 
 
PAHs are planar molecules composed of carbon and hydrogen atoms; however, as shown 
in Table 1, sulfur, oxygen and nitrogen atoms may readily substitute in the ring system to 
produce heterocyclic aromatic compounds (3, 8) such as dibenzothiophene (DBT). Heterocyclics 
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co-exist with PAHs and other aromatic compounds (methyl PAHs) in the environment (4). Clar’s 
postulate applies to all aromatics compounds with some limitations (5) and for simplicity in this 
dissertation heterocyclic aromatics will be referred as PAHs. Substitutions can result in 
molecular distortion of planarity that can potentially lead to more reactive and carcinogenic 
molecules. Consequently, the carcinogenic and mutagenic potential of PAHs depends on both 
abiotic and biotic transformations to more reactive metabolites (3), the mixture of PAHs and the 
organism exposed (9).  
The atmosphere, water, soil and biota all act as environmental sinks for PAHs, although 
soil is the major repository (8). In the United States, PAHs were ranked ninth in the priority list 
(PL) of hazardous substances by the Environmental Protection Agency (EPA) and the Agency 
for Toxic Substances and Disease Registry (ATSDR) in 2015. The priority list is a compilation 
of substances frequently found in the national priority waste sites list (NPWSL) that are 
determined to have risk to human health, having known toxicity and potential for human 
exposure (ATSDR website:
1
). Currently, there are 1337 sites in the NPWSL (EPA website:
2
).  
 
5.1.2. Sulfur-containing PAHs: DBT as a model chemical for bioremediation studies 
After carbon and hydrogen, sulfur is the most abundant element in PAHs and can exist in 
organic or inorganic fractions (10). In organic fractions, DBT is a major component, along with 
benzothiophene, benzonaphthothiophenes and their alkylated homologous (11). Sulfur-
containing PAHs in crude oil are of particular concern because of its detrimental effects in 
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human health, the environment and economy (10, 11). The Clean Air Act in United States 
established the legal requirements to lower the sulfur content from crude oil (Table 2).  
 
Table 2. Legal requirements of sulfur in diesel and gasoline (Transport website
5
). *it 
became available. 
Sulfur levels in diesel  500 ppm 15 ppm 
Highway Diesel Fuel  1993 2006* 
No road Diesel Fuel  2007 2010 
Locomotive and marine fuels  2007 2012 
Marine engine fuels  10,000 ppm (1%) 1000 ppm (0.1%) 
IMO* limits  2010 2015 
EPA limits  
 
2009 
Sulfur levels in gasoline Year 
120 - 300 ppm  2004 
30 - 80 ppm 2006 
 
DBT and its analogs are however widely distributed in sediments and urbanized areas 
(11, 12). Consequently, DBT it is typically used as a model chemical to study spatial distribution 
and quantification of thermodynamically stable sulfur-containing PAHs (11) and is the chemical 
of study in this dissertation for its applications in bioremediation.  
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DBT is a non-alternant PAH with both six- and five-rings fused together in an angular 
arrangement (Figure 2) (3). It is a hydrophobic compound with a water solubility of 7.9 µM and 
an octanol-water coefficient (Kow) of 4.44 (12). The lipophilic nature of DBT and other high 
molecular weight PAHs allows them to concentrate in aquatic animals and bioaccumulate 
through the food chain possessing an ecotoxicological risk (4). It was shown that dose dependent 
exposure of DBT to zebrafish embryos disrupted cardiac function. Higher dose was associated 
with morphological abnormalities at later developmental stages. Mortality was also reported for 
continuously exposed zebrafish embryos (12). In another study, DBT metabolites were shown to 
interact with estrogen receptors expressed in T47D human breast adenocarcinoma cell lines. 
Predicted DBT liver metabolites would also be estrogenic compounds (13). The frequency of 
DBT and PAHs in urbanized areas, the potential for human exposure and health threat makes 
them chemicals of concern and thus, need to be environmentally controlled.  
 
5.1.3. Remediation technologies for PAH contaminated soil  
In order to effectively remove PAHs, a prior characterization and evaluation of the 
contaminated site is required (14). Site-specific conditions, which include characteristics of the 
contaminants (e.g., volatility, concentration, mixture) and soil properties (e.g., permeability, 
porosity, and pH) are important considerations for effective remediation. There are several 
technologies for PAH contaminant removal in which the technology of choice will depend on the 
evaluation of the site, the monetary cost and the technologies available (14). These technologies 
are summarized in Table 3. 
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Physicochemical, chemical, thermal and biological are all types of treatments to be 
applied in-situ or ex-situ of the remediation site. The main advantage of in-situ compared to ex-
situ technologies is that the polluted soil does not need prior excavation and transportation in 
order to be treated, making it economically more attractive. However, treatments can require 
longer times and the uniformity as well as the efficacy is usually unclear. Similarly, the amount 
of waste to be treated and the moisture content of the soil are key cost drivers to consider ex-situ 
remediation (FRTR website
4
). In-situ and ex-situ technologies, their advantages and limitations 
will be discussed briefly in the following paragraphs. 
 
Table 3. Overview of remediation technologies. Adapted from (8, 14). 
Classification Technology  
Physicochemical  Solvent (water and organic solvents (15)) or vegetable oils 
extraction (16) with or without addition of surfactants (17) and/or 
cyclodextrins. Extraction with supercritical fluid (18, 19) or 
subcritical fluid. Both extractions complemented with physical 
agitation or sonication. 
Thermal Incineration, thermal desorption (20), thermally enhanced soil 
vapor extraction. 
Chemical  Chemical oxidation  with various oxidants (21) (e.g. hydrogen 
peroxide, Fenton’s reagent, potassium permanganate, activated 
persulfate), photocatalytic degradation, electroremediation (22) 
Biological  Biostimulation (23), bioventilation and bioaugumentation (24) or a 
mixture of those. 
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Ex-situ physicochemical treatment utilize physical separation (agitation or 
ultrasonication) and chemical extraction using a solvent or a supercritical or subcritical fluid (18). 
Chemical extractions use individual or mixture of chemically compatible solvents, surfactants 
(e.g. Tween 80) and/or include elevated temperature for PAH desorption from soil particles and 
extraction into the solvent. The use of non-toxic or biodegradable extraction agents are desirable 
attributes (8). Silva et al., (15) utilized acetone-ethyl acetate-water (40:50:10 ratio) as an 
environmental friendly mixture; where ethyl acetate was the main solvent contributing to the 
removal of xylene, naphthalene and hexadecane. Pollutant recovery efficiency increased with 
higher liquid to soil ratios, up to 95% (15). Use of sunflower and peanut oil with orbital agitation 
also showed promising results, however, oil to soil ratio adequate for PAH removal was 
prohibitively high and may not represent a viable solution (16).  
Subcritical fluid extraction utilizes water at high temperature (100ºC < T > 374ºC) and 
pressure (>221 bars) to retain its liquid state. Under these conditions the, dielectric constant, 
surface tension and polarity of water are reduced making it an effective alternative solvent 
(subcritical or superheated water) (14). The same principle is applied in supercritical extraction 
(SCE), but, a fluid (supercritical fluid: SCF) with a high affinity for PAHs is utilized instead of 
water. In SCE, excavated soil is placed in a pressure vessel and extracted with a recirculated 
stream of SCF. Once PAHs are transferred to SCF; the clean soil, the SCF and the solutes are 
separated by physical methods (18). Librando et al. (19) analyzed the recovery of 6 PAHs from 
sediment samples with varying pressure from 230–600 bars and at 2 temperatures (50 and 80ºC). 
Different co-solvents with CO2 as SCF were also tested. The best performance was obtained with 
5% methanol as co-solvent, 50ºC and 450 bars. These optimized parameters achieved above 90% 
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recovery of 5 PAHs from spiked soil. They concluded that better recovery was obtained with 
higher molecular weight PAHs (19), which is an advantage over bioremediation, since there are 
few microorganism capable of biodegrading high molecular weight PAHs (4). Nonetheless, there 
are disadvantages of ex-situ physicochemical treatments; for instance, PAHs need to be treat it 
following extraction and solvents used need to be regenerated (8, 16). Extractions need to be 
scale up to make them more economically feasible (8). Streams by-products can be generated 
during SCE and must also be treated, which increases the technology cost (18). 
Thermal remediation comprises the ex-situ technologies: incineration, thermal desorption 
and microwave frequency heating. Incineration consist in simply burning the contaminated soil 
at temperatures up to 1000ºC (25). It is one of the most effective and simpler remediation 
methods for removing oil contamination (14) but it emits toxic gases and uses high amounts of 
energy (7, 14). Thermal desorption uses heat to physically separate contaminants from soil. For 
PAH remediation, the temperature required must be higher than a PAHs boiling temperature. 
During thermal treatments, the number and concentration of PAHs changes due to parasitic 
reactions. PAHs may be transformed to several isomers, some being more toxic than their parent 
compound. For example Pope et al., empirically demonstrated that at high temperatures pyrene 
reacts with acetylene forming cyclopenta[c,d]pyrene and phenanthrene forms chrysene, both 
human cell mutagens (26). 
The production of free radicals with high redox potential is the basic principle of 
chemical oxidation treatments. The free radicals will oxidize through electrophilic addition or via 
hydrogen subtraction (14). For example, hydrogen peroxide produces hydroxyl radicals (
•
OH), 
which are able to react with alkanes and aromatic compounds. Since this reaction is not 
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considered kinetically fast enough, hydrogen peroxide is co-added with a transition metal 
(usually iron) as a catalyst to enhance radical formation, a mixture known as Fenton reagent. In a 
modified Fenton’s system in addition to hydroxyl radicals, hydroperoxide radicals (HO2•), 
superoxide anions (O2
•-
), and hydroperoxide anions (HO2
-
) are also formed. These radicals seem 
to degrade recalcitrant organic compounds. Efficiency is however impacted by high organic 
content and PAH adsorption onto soil, relative PAHs concentration and its specific chemical 
composition and mixture (21).  
Electroremediation is an in situ technology where electrodes are inserted directly into the 
contaminated soil from which a low intensity electrical current is distributed. It has been 
previously used for the removal of inorganic contaminants; however, recent efforts to expand 
this technology to remediate PAH contaminated soil are being developed (8). A charged base 
electromigration of species occurs towards the electrodes. Nonpolar species such as PAHs can 
migrate with the electro-osmotic flow of an aqueous solution. Addition of solubilizing agents 
(non-ionic surfactants, cyclodextrins), co-solvents (e.g. ethanol) and/or electrolytes in the 
aqueous solution are some of the strategies to increase desorption and solubilization of PAHs 
(22). Application of biosurfactants to this strategy remains to be investigated. After current 
exposure, soil contaminants are concentrated and recovered from an electrode chamber and 
subsequently treated (22). 
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5.1.4. Bioremediation as an alternative biotechnology  
Generally, bioremediation is the use of biological metabolisms for the removal of 
contaminants from the environment. Phytoremediation could also be included in this category; 
however, it will not be discussed in this dissertation as it is out of the scope of the research 
presented. Four strategies can be utilized in bioremediation with microorganisms: 
bioaugumentation, biostimulation, bioventilation or a combination of these. Bioaugumentation 
refers to the addition or enrichment of specific microorganisms that possess the metabolic 
capabilities resulting in increased biodegradation rates of pollutants on site (8). This strategy is 
applicable to sites that have insufficient amount of PAH degrading microbes or when the 
indigenous microflora does not possess the necessary metabolic capability (27). Typically, 
consortia of microorganisms are applied to the soil as there is not a single microorganism with 
the ability to degrade all the contaminants of a particular site (14). Dehydrogenase activity and 
CO2 measurements are often two parameters used to determine the potential efficiency of a 
consortia in situ. Szulc et al., (24) tested ten consortia for hydrocarbon degradation and 
discovered an association between dehydrogenase activity and CO2 emitted. The consortium 
having the highest dehydrogenase activity and CO2 emission values was selected for 
bioaugumentation use. They emphasize the need for the selection of an appropriate consortium 
for improved bioremediation. Their results demonstrated an enhanced removal of diesel oil 
compared to natural attenuation over a one year period (24).  
It is worth noting that the indigenous microflora of a PAH contaminated place can 
accomplish natural attenuation. In soil column experiments, 88% of PAH loss was attributed to 
biodegradation by the indigenous soil community (28). However, the rate of biodegradation is 
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generally lower than in laboratory settings (29). If environmental conditions are limiting factors, 
biostimulation with nutrients, surfactants and/or additional carbon sources is another strategy to 
improve biodegradation rates (14). Margesin and Schinner showed that after 447 days 
biostimulation with N-P-K fertilizer (C/N ratio of 20:1) decreased the hydrocarbon concentration 
by 66% compared with 41% achieved through natural attenuation (23). In another study, 
Boonchan et al., (30) tested 5 nonionic surfactants at concentrations below, above and at the 
critical micelle concentration (CMC). CMC is the minimum concentration required for a 
surfactant to form micelles. Surfactant micelle formation is one of the mechanisms proposed for 
PAH solubilization and consequent bioavailability increased (31). Effectively, the solubility of 
pyrene, fluoranthene and benzo[a]pyrene increased 700-, 500- and 10
4
-fold, respectively, with 
surfactant concentrations above CMC (30). In this experiment the biodegradation rate for 250 
ppm pyrene was reduced by 50% using Brij 35, Tergitol NP-10 and Tyloxapol non-ionic 
surfactants (5-10 g/L). Igepal CA-360 inhibited microbial growth, consequently inhibiting 
pyrene degradation (30). These results suggest that the efficacy of specific surfactants should be 
tested under the conditions that it will be utilized. Biostimulation can provide more suitable 
conditions for both indigenous and exogenous microbial populations (27).  
Bioventilation involves the introduction of oxygen to stimulate microbial growth and 
aerobic reactions. It has been shown to improve degradation efficiency 21% over natural 
attenuation of biodiesel on a 60 days’ time period (14).  
In contrast to other remediation technologies, which often result in partial breakdown or 
by-products, the products of bioremediation are water, gasses and minerals, requiring no further 
downstream process. Assuming that the necessary metabolic capability is present, biostimulation 
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through the addition of nutrients or biosurfactants is arguably the most widely used strategy to 
increase PAH bioavailability (31, 32).  
 
5.1.5. Biosurfactants and its potential in bioremediation 
Intentional augmentation of contaminated soil with microorganisms adept at producing 
biosurfactants is a promising method to improve current bioremediation technologies (24). In 
addition to catabolic enzymes (4, 33–36), microbial methods to address PAH solubilization and 
bioavailability may be required as a PAH molecular weight increases, which results in greater 
resistance to degradation (3, 31, 32). Bioremediation of hydrophobic pollutants is frequently 
limited by low abundance of microorganisms and poor chemical bioavailability, causing 
decreased biodegradation kinetics (23, 31).  
Biosurfactants interact with PAHs in solution and at water-particle and water-oil 
interfaces because of the amphipathic nature of their chemical structure. Those interactions make 
PAHs more soluble and bioavailable (31, 37). The production of both biosurfactants and 
hydrocarbon degradative enzymes in bacteria from PAH contaminated soil (38–40) and the 
effects of these biosurfactants on hydrophobic pollutant uptake (41) and biodegradation (37, 42, 
43) suggest an evolutionary adaptation by microorganisms to overcome low substrate availability. 
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5.1.6. Bacterial degradation of DBT  
Research on the microbial transformation of PAHs, their catabolic pathways and 
biodegradation kinetics have been extensively studied (4, 32, 44). Three degradation pathways 
have been described for DBT (45–49). Catabolism as well as additional metabolic processes for 
enhanced DBT degradation will depend on the genetic make-up of not only the consortia, but 
also upon specific species of microorganism. Metabolically removed sulfur from the DBT 
molecule can be utilized in primary metabolisms for the production of amino acids and enzyme 
co-factors (10, 47).  
The three DBT biodegradation pathways are shown in Figure 2 and discussed in the 
following subheadings:  
5.1.7. DBT biodegradation: 4S pathway 
5.1.8. DBT biodegradation: Kodama or lateral dioxygenation pathway 
5.1.9. DBT biodegradation: Angular dioxygenation pathway 
 
DBT oxidative enzymes are found in the cytoplasm, requiring transport of the 
hydrophobic DBT for degradation (50). How can DBT enter the cell membrane? - the 
mechanism is not clear, however, it was suggested that DBT dispersed by N,N’-dimethylformide 
in water (water/oil phase) may cross the cell membrane through simple diffusion but not in n-
tetradecane (oil phase), where an ABC-like transport system may have this role (51).  
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5.1.7. DBT biodegradation: 4S pathway 
Initial steps in this pathway are catalyzed by DBT monooxygenase and DBT-sulfone 
monooxygenase. Both of these flavin-dependent monooxygenases incorporate one oxygen atom 
into the sulfur atom in two steps process (Figure 2). A flavin reductase is required for full 
monooxygenases activity (49). A HPBS desulfinase then catalyzes the conversion of 
hydroxyphenyl benzene sulfonate into 2-hydroxybiphenyl (HBP) and sulfite (49, 52).  
The HBP product is highly hydrophobic finding its way back to the oil fraction. No 
calorific value is lost with this pathway and thus is an ideal desulfurization pathway for fuel 
processing (47, 53). The dsz genes coding for the enzymes involved in the 4S pathway have been 
described in Rhodococcus, Mycobacterium, Corynebacterium, Bacillus and Stenotrophomonas 
species (54–57).  
 
5.1.8. DBT biodegradation: Kodama or lateral dioxygenation pathway 
The Kodama pathway is described as a lateral dioxygenation pathway (4, 46). The first 
and most important step in this pathway is mediated by DBT dioxygenase. Reports indicate that 
DBT dioxygenase mutants lose their ability to metabolize DBT (58, 59). Ring-hydroxylating 
dioxygenases incorporate molecular oxygen at 1,2; 3,4 or the 9,10 positions of a PAH (Figure 2). 
This step is necessary for ortho-, meta- or para-cleavage of the aromatic ring. The position where 
oxygen will be incorporated would depend on the dioxygenase specificity. The metabolites 
produced are therefore dependent on DBT initial dioxygenation (4, 34, 48, 60). In 1993, Denome 
et al., (58) reported a DNA fragment that conferred Pseudomonas sp. C18 the capacity to oxidize 
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DBT. This DNA fragment contains dox genes with high sequence similarities to naphthalene, 
biphenyl, toluene and benzene dioxygenases from Pseudomonas putida G7 (nah genes) (58, 61). 
The nah genes conferred G7 the ability to degrade naphthalene (62). Several groups of nah-like 
genes and phn genes have been described. The nah-like and phn genes conferred Pseudomonas 
strains the ability to degrade naphthalene and phenanthrene, respectively (61, 62).  
 
5.1.9. DBT biodegradation: Angular dioxygenation pathway 
The angular dioxygenation pathway will not be discussed in this dissertation as there are 
very few reports describing this biodegradation pathway and most of the DBT metabolites have 
not been identified, as well as microorganisms, with the proper catalytic enzymes (46) (Figure 
2).  
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Figure 2. DBT metabolic pathways described in microorganisms. Unstable 
metabolites in brackets have not been observed directly. Figure was adapted and modified from 
(45, 46, 49, 59). DBT: dibenzothiophene. DBTO: dibenzothiophene sulfoxide. DBTO2: 
dibenzothiophene sulfone. HPBS: hydroxyphenylbenzene sulfonate. 2-HBP: 2-hydroxybiphenyl. 
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5.1.10. Burkholderia sp. C3, a non-pathogenic environmental isolate 
Burkholderia sp. C3 is a PAH degrading bacterium isolated from a former oil gasification 
company site on Hilo, Hawai’i. The waste product generated by the company was a tar rich in 
PAHs. The tar was buried in a tank after the company was closed in 1965. Later the bottom of 
the tank was excavated and a portion of the tar with contaminated soil was stored in a plastic 
sheet in a berm on site. In the year 2000, heavy flooding swept PAH-contaminated silt onto the 
surface of five Hawai’i County Park soccer fields. In the same year this site was declared an 
emergency response site by the EPA and samples were taken and analyzed in our laboratory. 
Thirteen PAHs were identified and 19 bacterial strains were isolated (63). The C3 isolate was 
able to completely degrade 40 ppm of phenanthrene in 7 days using a 1,2 and 3,4 dioxygenation 
system (34). Tittabutr et al. (35) then reported the ability of C3 to degrade 7 additional aromatic 
pollutants. C3 degraded 40 ppm of DBT in 7 days (35). Furthermore, nag-like and phn cluster of 
genes were isolated in C3. Both clusters conferred E. coli the ability to degrade phenanthrene, 
naphthalene and DBT to some extent (35).  
 
5.1.11. Impact of this dissertation 
This study was designed to investigate glycerol, as a co-substrate, to biostimulate the 
degradation of DBT by C3. Previously unpublished studies indicated that glycerol enhanced the 
biodegradation of DBT. Glucose was also investigated as a co-substrate but DBT biodegradation 
inhibition was detected instead. Early DBT solubilization, foam formation, and DBT degradation 
were observed in DBT biodegradation cultures induced for 12 hours with glycerol. This was not 
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observed in cultures with DBT alone, suggesting the secretion of a surfactant agent. In 
Pseudomonas species, glycerol readily enters into glycolysis and β-oxidation and De novo 
synthesis of fatty acid (FAS II) lipid pathways, affecting the production of rhamnolipids (RLs), a 
glycolipid biosurfactant and the production of polyhydroxyalkanoic acid (PHA) granules 
formation (64, 65). There are reports describing the production of RLs in Burkholderia species as 
well (66, 67). Here, we report up to an 18-fold enhancement in DBT biodegradation induced by 
glycerol cometabolism in C3. Four mechanisms were induced in C3 by DBT cometabolism with 
glycerol. (1) Glycerol-induced accumulation of DBT degradative enzymes. All enzymes from 
DBT, phenanthrene and naphthalene degradation pathways were available for degradation of 
xenobiotics in C3 treated with 50 mM glycerol. (2) Glycerol supported an increase in C3 
biomass. Glycerol assimilated in C3 basal metabolism as phosphorylated glycerol and glycerate. 
(3) Glycerol-induced accumulation of intracellular PHA granules. Glycerol-induced PHA 
granule formation at 2 days and this associated with enhanced DBT degradation (4) Glycerol 
stimulated a dual function in C3 as a RL producer and a DBT degrader. The increase of RL 
biosynthesis and secretion facilitated biodegradation of DBT in C3. To our knowledge, this is the 
first study showing a direct association between RL biosynthesis and DBT biodegradation 
induced by glycerol in Burkholderia species. 
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6. CHAPTER 2: HYPOTHESES, RATIONALES AND AIMS 
6.1 HYPOTHESIS 1: GLYCEROL ENHANCES COMETABOLISM OF DBT IN 
BURKHOLDERIA SP. C3 
 
6.1.1. Rationale: Glycerol as a co-substrate biostimulates DBT biodegradation in C3 
via increased biomass  
There are many parameters affecting bioremediation of PAHs-contaminated sites. 
Besides an appropriate microbial consortium, type and concentration of nutrients and the actual 
site conditions (e.g. soil moisture, pH, temperature) are stressor factors that have an effect on 
biodegradation efficiencies (27). This study was designed to follow a biostimulation strategy to 
investigate the influence of glycerol in the DBT biodegradation ability of C3. Glycerol is the 
main by-product in the production of biodiesel. It is obtained during transesterification of 
vegetable oils and animal fats, accounting for about 10% (w/w) of biodiesel. Biodiesel is one of 
the most promising alternative fuels, although its current production cost is relatively high. New 
applications of glycerol would make biodiesel production more cost-effective (68, 69).  
Glycerol is a small uncharged molecule that can cross the cell membrane through passive 
diffusion. However, under low extracellular glycerol concentrations, bacterial cells limited to 
passive uptake have a growth disadvantage (69). The gene products of the glp regulon participate 
in facilitated diffusion and metabolism of glycerol and its derivatives in Escherichia coli. GlpF is 
a highly selective channel for non-ionic compounds (69). Not to be confused with glycerol-3-
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phosphate (G3P) transporter (GlpT), which uptakes G3P (70). Interaction of GlpF with glycerol 
kinase (GlpK) stimulates glycerol phosphorylation by the same enzyme. It was shown that the 
Km of GlpK decreased upon interaction with GlpF (71). Intracellular G3P can be further 
metabolized aerobically via G3P dehydrogenase (GlpD) or anaerobically via G3P dehydrogenase 
(GlpA) as shown in Figure 3.  
 
Figure 3. Glycerol uptake and early assimilation in Escherichia coli adapted from 
(70). Substrates: G3P, glycerol-3-phosphate; DHAP, dihydroxyacetone phosphate; GAP, 
glyceraldeahyde-3-phosphate, FDP, fructose-1,6-diphosphate. Proteins: GlpF, glycerol 
facilitator; GlpT, glycerol-3-phosphate transporter; GlpK, glycerol kinase; GlpD, glycerol-3-
phosphate dehydrogenase; GlpA, glycerol-3-phosphate dehydrogenase and GspA, glycerol-3-
phosphate synthase. 
 
If supplied into basal metabolism, glycerol can support bacterial growth and possibly 
enhanced the biodegradation rate of DBT, simply by increasing the biomass of C3. For aerobic 
metabolism, GlpK phosphorylates glycerol into G3P which is then converted to 
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dihydroxyacetone phosphate by G3P dehydrogenase (70). Glycerol can also enter to glycolysis 
via glycerate-3-phosphate. GlpK has four binding sites for glycerol and for fructose-1,6-
diphosphate (FDP). Feedback inhibition by FDP is the dominant repressing mechanism for 
glycerol utilization in the presence of glucose (70). In order to determine the glycerol effects on 
DBT co-utilization and C3 growth the aims below were proposed: 
 
6.2. HYPOTHESIS 1: AIMS 
6.2.1. Aim 1: Determine the optimum concentration of glycerol to induce DBT 
cometabolism in C3  
6.2.2. Aim 2: Measure C3 growth with different concentrations of glycerol in the 
presence and absence of 0.5 mM DBT  
6.2.3. Aim 3: Analyze proteins involved in DBT and glycerol degradation from C3 
cultured with treatments: A, 0.5 mM DBT; B, 50 mM glycerol; C, 0.5 mM 
DBT with 50 mM glycerol; and D, 0.5 mM DBT with 50 mM glycerol and 2 
mM 2-bromooctanoic acid (OC). 
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6.3 HYPOTHESIS 2: GLYCEROL STIMULATES THE SYNTHESIS OF PROTEINS 
THAT MEDIATE LIPID METABOLIC PATHWAYS AND POLYHYDROXYALKANOIC 
(PHA) LIPID GRANULE FORMATION IN C3 
 
6.3.1. Rationale: Glycerol molecule and its assimilation in bacterial cells 
Glycerol is used for carbohydrate and lipid synthesis in bacteria (Figure 3). G3P can be 
directly used by G3P acyltransferase for biosynthesis of L-1-phosphatidyl-glycerol. The end 
products and intermediaries of this biosynthetic pathway served then as substrates for the 
synthesis of phospholipids such as phosphatidylcholines, phosphatidylethanolamine and 
cardiolipins (BioCyc website
6
). In 1964, Tepper et al., (72) demonstrated that glycerol-grown 
Mycobacterium phlei cells had higher non-essential lipid content than glucose-grown cells (72). 
Glycerol readily enters into β-oxidation and De Novo synthesis of fatty acid (FAS II) pathways. 
These pathways produce the lipid precursor for the biosynthesis of PHAs lipid storage granules 
(73, 74).  
Pseudomonas species have two PHA synthase genes (phaC1 and phaC2) found in the 
mclPHA gene cluster. Additionally in this cluster, PHA depolymerase (phaZ), a transcriptional 
activator (phaD) (75) and two phasin proteins (phaFI) are also coded. It is proposed that phasins 
have a structural role in granule formation and stabilization (76). PHA utilization and storage 
increased the production of molecules with tension-lowering properties (77) such as RL (78). 
Similarly, PHA accumulation affected cell-surface hydrophobicity (77) and increased heat-stress 
tolerance (78). All features relevant for fitness in a hydrocarbon-contaminated environment. 
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Inhibition of β-oxidation and FAS II by 2-bromoalkanoic acids suppresses the biosynthesis of 
PHAs in Pseudomonas species (64, 65). It was proposed that 2-bromoalkanoic acid may target 
PhaG involved in producing the acyl carrier protein (ACP)-lipid precursor for PHA synthesis (65, 
79). Does C3 forms PHA granules and do these enhanced DBT degradation? If PHA granule 
accumulation has an effect on DBT biodegradation in C3 induced by glycerol, the use of 2-
bromoalkanoic acid should not only inhibit degradation of DBT, but also the production of PHA 
granules.  
 
6.4. HYPOTHESIS 2: AIMS 
6.4.1. Aim 1: Determine the effect of 2-bromohexanoic (HEX) and OC acid, inhibitors of 
β-oxidation and FAS II lipid pathways at 2 and 5 mM concentrations on 
DBT biodegradation induced by 50 mM glycerol and measure C3 growth 
6.4.2. Aim 2: Profile proteins from C3 cultured with treatments: A 0.5 mM DBT; B, 50 
mM glycerol; C, 0.5 mM DBT with 50 mM glycerol; and D, 0.5 mM DBT 
with 50 mM glycerol and 2 mM OC. 
6.4.3. Aim 3: Analyze proteins involved in PHA synthesis from C3 cultured with 
treatments: A 0.5 mM DBT; B, 50 mM glycerol; C, 0.5 mM DBT with 50 
mM glycerol; and D, 0.5 mM DBT with 50 mM glycerol and 2 mM OC. 
6.4.4. Aim 4: Visualize PHA lipid granules in C3 grown with 0.5 mM DBT with or 
without 50 mM glycerol and with 2 mM of OC or HEX inhibitor 
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6.5. HYPOTHESIS 3: GLYCEROL INDUCES LIPID PRECURSOR SUPPLY FOR 
BIOSYNTHESIS OF RL BIOSURFACTANT  
 
6.5.1. Rationale: Glycerol is readily available in RL anabolic pathways 
PHA and RL synthesis have a close metabolic relationship. PhaG utilizes R-3-
hydroxydecanoyl-CoA to produce PHA or R-3-hydroxyoctanoyl-CoA can be further converted 
to hydroxylalkanoic acid (HAA), lipid precursor for RL synthesis (Figure 4) (74). RL is a 
glycolipid biosurfactant extensively studied in Pseudomonas species and its potential in the 
bioremediation field (37, 38, 80, 81). Biosynthesis of RL involves the anabolic pathways shown 
in Figure 4. Biosynthesis of dTDP-L-rhamnose is accomplished in several steps by RmlABCD 
from the substrate, D-glucose-1-phosphate (82). The lipid precursors of HAA by HAA synthase 
(RhlA) are supplied from both -oxidation and FAS II pathways. β-Oxidation pathway produces 
R-3-hydroxydecanoyl-CoA via an enoyl-CoA hydratase/isomerase (RhlYZ), which is 
subsequently utilized by RhlA to produce HAA (64). FAS II pathway produces R-3-
hydroxyacyl-ACP that is directly used by RhlA to synthesize HAA (83). Additional steps 
catalyzed by RhlG and PhaG to produce HAA have also been described in literature (65, 73, 84). 
HAA and dTDP-L-rhamnose are reacted via the catalysis of rhamnosyltransferase 1 (RhlB) to 
produce monorhamnolipids (85, 86). Monorhamnolipids can then react with another dTDP-L-
rhamnose under the catalysis of rhamnosyltransferase 2 (RhlC) to produce dirhamnolipids (87).  
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Figure 4. Biosynthesis of polyhydroxyalkanotes (PHA) and rhamnolipids (RLs) in 
Pseudomonas. Figure was adapted and modified from (64, 73, 88) Glycerol directly supplies 
into De novo synthesis of fatty acid pathway (FAS II). Mono-RL: Monorhamnolipid. Di-RL: 
Dirhamnolipid. ACP: acyl carrier protein. 
 
Is C3 producing RLs and do these enhance DBT degradation? If RL have an effect on 
DBT biodegradation, the use of 2-bromoalkanoic acid should inhibit degradation of DBT and 
RLs. The aims below were designed to answer these two interrogations.  
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6.6. HYPOTHESIS 3: AIMS  
6.6.1. Aim 1: Identify rhlABC genes in which their genetic products catalyze the main 
steps on RL biosynthesis  
6.6.2. Aim 2: Quantify the effects of RL standard on DBT degradation and C3 growth 
6.6.3. Aim 3: Determine the tensioactive properties of the DBT biodegradation cultures 
6.6.4. Aim 4: Determine the effects of HEX and OC, β-oxidation and FAS II pathways 
inhibitors on DBT biodegradation induced by different glycerol 
concentration and RL synthesis 
6.6.5. Aim 5: Analyze proteins involved in RL synthesis from C3 cultured with 
treatments: A 0.5 mM DBT; B, 50 mM glycerol; C, 0.5 mM DBT with 50 
mM glycerol; and D, 0.5 mM DBT with 50 mM glycerol and 2 mM OC. 
6.6.6. Aim 6: Characterize RL congeners via HPLC separation and MALDI-TOF/TOF 
identification 
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7. CHAPTER 3: METHODOLOGY 
7.1. CULTURING OF BURKHOLDERIA SP. C3 
C3 growth from glycerol stock at -80ºC. C3 was plated from a 20% (v/v) glycerol stock 
at -80ºC and incubated at 30ºC for two days in LB agar. No more than 3 consecutives plate 
transfers were done as less consistent results might be obtained which would be attributed to C3 
cell mutations. After a third transfer, C3 cells were newly plated from a 20% (v/v) glycerol stock 
stored at -80ºC.  
C3 preparation for DBT biodegradation cultures. C3 cells from LB plates were grown 
overnight in LB rich medium at 30ºC and washed three times with minimal medium (MM) (89) 
by centrifugation at 5850 g for 7 min. C3 cells were then adjusted to an OD600 of 0.5 in MM, of 
which 0.5 mL were inoculated to each of the tubes at a concentration of approximately 0.05 
OD600. The cultures inoculated at 0.20 OD600 were prepared in the same manner. In C3 growth 
curves, cultures with glycerol, but without DBT were also prepared.  
 
7.2. PREPARATION OF DBT BIODEGRADATION CULTURES 
DBT biodegradation cultures preparation. Test tubes were baked at 450ºC for a 
minimum of 3 h. A stock solution of 5 mg/mL (5000 parts per million; ppm) of DBT dissolved 
in acetone was prepared. In each test tube, 100 µL of DBT stock solution was added, followed 
by complete evaporation of acetone under N2 gas. Five mL of MM and an appropriate volume of 
50% (v/v) aqueous glycerol solution were then added. The final concentration of DBT was 0.5 
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mM (100 ppm), while the final concentration of glycerol was as follows: 0, 0.05, 0.5, 5, 50, 200 
or 500 mM. In the RL biosynthesis inhibition experiments, the final concentration of HEX and 
OC was 2 or 5 mM. The appropriate volume to add was calculated using density of HEX and 
OC. In the RL fortification experiments, the final RL concentration was 20 µg/mL resuspended 
in water. Cultures were incubated in a rotary shaker at 30ºC at 200 rpm. Autoclaved C3 cells 
were used as controls. All experiments were done in at least three biological replicates.  
 
7.3. EXTRACTION AND ANALYSIS OF DBT 
DBT extraction. DBT was extracted from biodegradation cultures incubated for 0, 1, 4, 7 
and 10 days and analyzed according to Akhtar et al., (90). After the culture was acidified to pH 
2-3 with HCl, DBT was extracted with ethyl acetate by vortex 3 times for 2 min. Between vortex 
intervals, tubes were open for at least 1 min to prevent bubble formation. Long glass blue capped 
tubes were used to ensure an increased mixing area. The upper layer (organic phase) was 
collected and filtered with a 0.2 µm (pore size) polyvinylidene fluoride (PVDF) membrane. 
PVDF membranes were used to filter organic solvents.  
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Figure 5. HPLC chromatogram of DBT standard. Standard concentration used was 
100 ppm. Ethyl acetate (solvent peak) and DBT retention times were 6.925 and 20.525 minutes, 
respectively. AU: arbitrary units. All experiments were done at least in triplicates. 
 
DBT analysis with HPLC. DBT was analyze on an Agilent 1100 series high performance 
liquid chromatograph (HPLC) equipped with an Aqua C18 column (150 x 4.60 mm, 5 µm) 
(Phenomenex, Inc.) and detected at 245 nm. Mobile phase was 60% aqueous ACN and the flow 
rate was 1 mL/min. An injection volume of 10 µL was used for standards and experimental 
samples. The total chromatographic run was 25 min. Experimental samples were quantified with 
a DBT standard curve ranging from 5-100 ppm. Standard was resuspended in ethyl acetate. 
Retention time (RT) of ethyl acetate was 6.9 min, whereas, RT of DBT was 20.5 min as shown 
in Figure 5. 
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7.4. PROTEIN EXTRACTION AND PREPARATION 
Protein extraction. C3 cells were collected from biodegradation cultures at day 2, 
washed 3 times with mQ water and the proteome was extracted according to a previously 
reported method (91) with few modifications. A lysis buffer was prepared by mixing 9 mL of a 9 
M urea solution with 1 mL of 10x protease inhibitor solution. Protease inhibitor solution was 
prepared from Sigmafast
TM 
protease inhibitor tablet (Sigma-Aldrich, Milwaukee, WI). After 
complete removal of medium by centrifugation at 5850 g, cell pellets were resuspended in 700 
µL of lysis buffer followed by immediate vortex to ensure a complete and uniform sample. 
Otherwise, cells would clump together making a less effective cell membrane disruption. This 
cell suspension was added to a 300 µL of lysis buffer solution in a screw cap vial that was 2/3 
prefilled with 0.5 mm (diameter) glass beads (BioSpec Products, Bartlesville, OK). Cell 
membranes were disrupted by 6 cycles of bead-beating at a maximum speed for 60 s on a mini-
beadbeater (BioSpec Products) and on ice for 60 s. Cell debris was removed by centrifugation at 
20,817 g for 15 min.  
 
Protein quantification and visualization. A supernatant was collected and protein 
concentration was measured with Bradford protein assay (Bio-Rad, Hercules, CA). If protein 
concentration was below 1.2 mg/mL, protein extracts were run through an Amicon Ultra-0.5 mL 
centrifugal filter (3K cut-off; Millipore, Bay city, MI) to concentrate proteins on the filter. The 
filter was then washed with 500 L of mQ water. An amount of 36 µg of protein was loaded on a 
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12% SDS-PAGE run at 100 V constant for 1 hour and 30 min. Protein bands were visualized 
with Coomasie blue.  
 
Protein sample preparation for LC-MS. From each gel lane, 12 to 14 gel fractions (1 
mm
3
) were obtained and washed with 25 mM ammonium bicarbonate (NH4HCO3)/50% ACN 
until gel pieces became clear. The protein disulfide bonds were reduced with dithiothreitol 
(DTT) incubated at 56ºC for 30 min. The exposed cysteine residues were alkylated with 
iodoacetamide (IAA) at room temperature for 20 min. Gel pieces were dehydrated with 100% 
ACN prior to the DTT reduction and IAA alkylation steps to ensure a full absorption of the 
solutions. Washing with 100 mM NH4HCO3 and dehydration with 100% ACN was followed 
prior in-gel protein digestion with Trypsin/Lys-C Mix, Mass Spec Grade (Promega, Fitchburg, 
WI) at 37ºC for 16-18 hrs. Protein digests were desalted and concentrated with Pierce
®
 C18 tips 
(Thermo Scientific, Rockford, IL) and then analyzed on a Bruker nanoLC-amaZon speed ion 
trap mass spectrometer system (Bruker Daltonics, Billerica, MA). The peptides were separated 
on a C18 analytical column (0.1×150 mm, 3 µ, 200 Å, Bruker) with gradient elution from 5%-
65% ACN in 0.1% formic acid for 80 min after 2-min running delay. After 90 min elution, the 
mobile phase was changed to 95% ACN in 0.1% formic acid and remained for 10 min, followed 
by column equilibration with 5% ACN in 0.1% formic acid for 20 min for the next run. The flow 
rate was 800 nL/min. The peptides were detected using a capillary voltage of 1600 and the 
temperature of the heated capillary was 149.5ºC. A survey scan from m/z 400-3000 was followed 
by data-dependent MS/MS of the 10 most abundant ions and 0.5 Da instrument error. Dynamic 
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exclusion was set to repeat the same precursor ion twice and followed by excluding it for 0.8 
min. 
 
7.5. PROTEIN IDENTIFICATION AND ANALYSIS 
Raw file conversion software. Raw files (file type = BAF) were converted to mascot 
generic format (.mgf) and .xml with DataAnalysis software (Bruker Daltonics). Other software 
such as ProteoWizard (92, 93), software package available for download at 
http://proteowizard.sourceforge.net/ can be used for free access. If so, 32-bit version must be 
used because the 64-bit version is not currently compatible with the 64-bit Bruker peak picker. A 
filter for peak picking of all MS levels using the vendor peak picker option should be applied.  
 
Raw file conversion with DataAnalysis software. Mass spectrometry (MS) and tandem 
MS (MS/MS) compounds are found on the basis that the MS/MS spectra of a specific compound 
contains an identical parent ion within a narrow mass to charge ratio (m/z) and time range. When 
compounds contained more than one MS/MS spectrum, DataAnalysis software selects the best 
MS spectrum (higher intensity and best resolution) as precursor MS spectrum. Apex was used as 
the peak picking algorithm and absolute intensity threshold was set to 100. Parameters for MS 
and MS/MS compound find were selected based on the capabilities of the instrument utilized. 
These parameters were: Intensity threshold = 100,000, RT window = 0 and option = fragments 
qualified by amino acids was checked. Even though a peptide molecular mass (M+H
+
) is 
automatically generated in DataAnalysis, MS and MS/MS spectra were deconvoluted via 
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resolved-isotope deconvolution method prior to compound identification. For this, the minimum 
percentage abundance of a signal relative to the largest one in the spectrum was set to 5 for MS 
and MS/MS and the maximum charge was set to auto. Finally, the compounds were exported to 
.xml and .mgf file formats checking the global charge limitation option and setting the intensity 
threshold for non-deconvoluted ions to 50 and export N most abundant non-deconvoluted ions to 
500. The same parameters were used for each .raw file generated. 
 
Protein database and database search. Database containing canonical and isoform 
2,628,482 protein sequences from Burkholderiales (Uniprot taxonomy: 80840) was downloaded 
in FASTA format from the UniProt Knowledgebase on April 4, 2016. Additional databases were 
constructed based on metabolic pathway and/or organism of interest. For xenobiotic degradation: 
canonical and isoform 35 protein sequences from “Burkholderia sp C3” and “Burkholderia sp 
DBT1” (searched terms) was downloaded in FASTA format from the UniProt Knowledgebase 
on October 26, 2016. For lipid metabolism and RL synthesis: canonical and isoform 492 protein 
sequences from “Burkholderia” (Uniprot taxonomy: 32008, fixed searched term) and the 
different protein names (variable term) was downloaded in FASTA format from the UniProt 
Knowledgebase on April 4, 2016. For PHA synthase: canonical and isoform 23 protein 
sequences from PHA synthase and Burkholderiales (fixed searched terms) was downloaded in 
FASTA format from the UniProt Knowledgebase on October 25, 2016. 
The database search was conducted with Myrimatch search engine (94) and the 
configuration used was as follows: Instrument type = Ion Trap, Precursor Mass = auto, Enzyme 
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= Trypsin/P, Average precursor tolerance 1.5 m/z, Fragment tolerance = 0.5 m/z and Mono 
precursor tolerance = 10 ppm. Modifications = carbamidomethyl (fixed) and Methionine 
oxidation (variable).  
 
Data normalization. Spectral counts of proteins identified in each treatment were 
obtained with IdPicker software. Treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; C, 50 
mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. Filters to 
match peptide to MS/MS spectra were: Maximum false discovery rate (FDR) of 1% and 1 
minimum spectrum per peptide (PSM) and per match. In order to match peptides to proteins, a 
minimum of 2 distinct peptides and spectra and 2 minimum additional peptide were allowed (95, 
96). Data were normalized according to (97) assumption that MS/MS intensities are equal to 1 
and without considering the peptide length. A Log(normalized count + 1) was applied and the 
normalized data was compared to the raw data (Figure 6). An analysis of variance (ANOVA, p-
value <0.05) was done to search for statistically significant protein abundance changes with 
DEseq (98). In order to create a matrix for the statistical design, a principal component analysis 
was done. This analysis showed that glycerol and the interaction of glycerol*DBT are the 
principal factors having an effect on the data clustering, thus DBT was excluded as a factor in the 
design. To define the value of the glycerol*DBT interaction term, the DBT degradation rate 
values were used. The rate to which the inhibitor decreased DBT biodegradation (treatment D) 
relative to treatment C was calculated and inputted in the matrix. The Matrix design was as 
follows: 
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Treatment Glycerol 
term 
Glycerol*DBT 
interaction term 
A 0 0 
B 1 0 
C 1 0.7 
D 0 0.7 
 
The logFC term was calculated and is shown in Table 6, Table 8,Table 11 andTable 13. 
This value represents the effect size of the glycerol*DBT interaction term. When the LogFC is 
upregulated, indicates that the glycerol*DBT interaction had a positive effect on the protein 
abundance of treatments that contained this interaction (Treatments C and D). It has the opposite 
effect if the LogFC is downregulated. A p-value was also shown for each protein of these tables. 
Graphs were done with InfernoRDN (Previously DAnTE) -omics software (98).  Proteins that 
were detected in the 3 biological replicates were considered for the analysis.  
 
 
Pathway and GO search. Excel files were re-formatted (e.g. column 1 = gene name), 
converted to a tab delimited file and uploaded to MetaCyc database (Private account) to search 
for biological relevance of the significant proteins detected (Table 13). A smart table was created 
(November 17, 2016) and the molecular function, biological process (Gene Ontology terms, GO) 
and pathway involved of each protein was searched. 
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Figure 6. Data normalization. Treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; 
C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. 
Biological replicates were 1, 2 and 3. Data followed a more normal trend after normalization. 
 
7.6. EXTRACTION, RESTRICTION DIGESTION AND LIGATION OF C3 
GENOMIC DNA 
Genomic DNA (gDNA) of C3 was extracted with an ultraclean microbial DNA isolation 
kit from MO BIO laboratories according to the manufacturer’s instruction. Two micrograms of 
gDNA were digested using 20 units of HindIII and 20 units of NdeI. Digestions were incubated 
at 37ºC for 3 h. Restriction enzyme was heat inactivated at 65ºC for 20 min. Proper digestion for 
inverse PCR (iPCR) with fragments above 1 Kb was checked on a 1% agarose gel. One 
microgram of digested DNA was self-ligated with 9 units of ligase. Ligations were incubated at 
15ºC overnight in a thermocycler. Self-ligated gDNA was precipitated and washed with ethanol 
and resuspended in DNase free water.  
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7.7. IDENTIFICATION OF RHLABC GENES 
Primer design. Degenerative primers were designed based on conserved regions of 13 
rhlB and 55 rhlC gene sequences from Burkholderia species collected from the NCBI database 
and using Geneious Pro 5.6.7 (Biomatters limited, Auckland, New Zealand) multiple sequence 
alignment default options. Inverse PCR was done using a high fidelity polymerase (Finnzymes, 
Thermo Scientific), degenerate primers for rhlB and self-ligated genomic DNA as template. PCR 
products were sequenced in duplicate and primers were designed based on the newly sequenced 
PCR product until a complete self-ligated plasmid was assembled. 
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Table 4. Inverse PCR primer information. Ta: annealing temperature. bp: base pair. Y: 
cytosine or thymine. K: guanine or thymine. R: adenine or guanosine. B: cytosine, guanine or 
thymine. 
Primer name Primer sequence (5’  3’ direction) Ta (ºC) 
rhlB_F 
rhlB_R 
F   GCTACGTGTCGGTGCAGGTGTC  
R   CGTCGTTGAACAGCGCAAACCC 
40 
rhlseq_F1 
rhlseq_R1 
F   TGCTGTGTCTGTTTCCGGACTG 
R   GCCACGCGGAATCGTCAGACGC 
60 
rhlseq_F2 
rhlseq_R2 
F   TTCGATAACGCACAGCGCGTCG 
R   CCATTGCGCGCCGATCAGCACG 
60 
rhlseq_F3 
rhlseq_R3 
F   ATCAGTTCGATAACGCACAGCG 
R   GCGATACTGTGAATACGCACGG 
60 
rhlseq_F4 
rhlseq_R4 
F   GAGAGTGTCATTCTGATCAACG  
R   CGAAGTAATCGAAAATCGCTGT 
60 
Plasmid check F1   
Plasmid check R1   
F   GAAGCAGGCTTTGCCGAATTAC 
R   GCGTGGAAAGATAGCGGTAGTT 
60 
Plasmid check F2  
Plasmid check R2  
F   AGTCGGGCTATCGCTGATTTTC 
R   AACATCTGCCTCAATAGCAGCC 
60 
Plasmid check F3  
Plasmid check R3  
F   CTACCGCTATCTTTCCACGCTC 
R   GGCGATGTTTGTGATGTTTGCA 
60 
rhlC_F 
rhlC_R 
F   GCGCTGTTCGAYCAGGAYTCG 
R   GCCGATCCGRTGCKBCAGCA 
62 
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DNA sequence assembly and identification. Sequences were assembled using Geneious 
Pro 5.6.7. Open reading frames (ORFs) were identified using the fgenesB bacterial operon and 
gene prediction program on March 11, 2016 (http://www.softberry.com/). Sequence homology 
was determined using UniProt Knowledgebase (http://www.uniprot.org/) and gene cluster 
homology was determined using Burkholderia Genome database (http://burkholderia.com/) and 
BLASTX algorithm accessed on May 4, 2016. The complete set of primer pairs utilized for 
identification of rhlABC genes is specified in Table 4. 
 
7.8. EXTRACTION AND QUANTIFICATION OF RL 
RL extraction. RLs were extracted according to Abdel-Mawgoud et al. (99). Briefly, 
cells were removed at day 2 by centrifugation at 5850 g for 10 min and filtration with a 0.2 µm 
pore size. The medium was extracted with ethyl acetate 3 times. The extracts were combined and 
dried under a gentle stream of N2 gas, followed by resuspending the residues in 0.5 mL of 
methanol. The same procedure was applied to a RL standard (50 µg/mL) dissolved with 5 or 50 
mM glycerol in MM.  
 
RL quantification. RLs were quantified using an orcinol assay (100) [0.19% orcinol 
(w/v) in 53% sulfuric acid (v/v)]. An aliquot of 250 µL of sample was collected, dried and 
resuspended in 250 µL of water. To 100 µL of RL extract, or varying concentrations of a RL 
standard, 900 µL of the orcinol solution was added. Mixtures were incubated for 30 min at 80ºC. 
Absorbance was read at 421 nm. A RL standard curve was prepared in a range of 0 and 500 
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µg/mL. The remaining 250 µL resuspended in methanol was used for HPLC fractionation and 
RL identification via matrix assisted laser desorption ionization (MALDI)–time of flight (TOF). 
 
7.9. CHARACTERIZATION OF RL CONGENERS VIA MATRIX ASSISTED LASER 
DESORPTION IONIZATION-TIME OF FLIGHT/TIME OF FLIGHT (MALDI-TOF/TOF) 
RL fractionation. RLs extracted were fractionated according to (99) on an Agilent 1100 
series HPLC equipped with an Aqua C18 column (150 x 4.60 mm, 5 µm particle size; 
Phenomenex, Inc.) and detected at 241 nm. RLs were eluted within a 10 min 70 to 90% 
ACN/water gradient. Both solvents (ACN/water) also contained 2 mM ammonium acetate, pH 
8.0-8.5. Three RL fractions were collected at 4-5 (F1), 5-6 (F2) and 7-8 (F3) min as shown in 
Figure 20. These fractions were dried to completion in a speed vacuum at 45ºC and resuspended 
in 10 µL of 10% ACN/water. Samples were desalted with Pierce
®
 C18 tips (Thermo Scientific) 
with the following modifications: Trifluoroacetic acid was not used as is recommended for 
peptide desalting. F1 and F2 samples were bound to the C18 tip 10 times, washed 5 times with 
5% ACN and eluted with 10 µL of 70% ACN. The same tip can be used for multiple times of the 
sample cleanup and concentration. Samples were dried to completion at 45ºC and resuspended in 
2 µL of 50% ACN containing 40 mg/mL of 2,5-dihydroxybenzoic acid (DHB). One µL of 
matrix was spotted on the target plate, air-dried and then 1 µL of sample/matrix mixture was 
spotted. 
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RL identification. RL congeners were identify on a MALDI-TOF/TOF ultraflex III mass 
spectrometer (Bruker Daltonics) operated in positive, reflectron mode following the procedures 
from (101) with modifications. Matrix was 40 mg/mL of DHB dissolved in 50% ACN/water. 
The instrument was calibrated with degree of polymerization (DP) series: maltotriose hydrate 
(DP3, MW: 504.44 g/mol), maltotetraose (DP4, MW: 666.57 g/mol), maltopentaose (DP5, MW: 
828.71 g/mol) and maltohexose (DP6, MW: 990.85 g/mol) (102). Each DP series formed M-Na
+
 
and M-K
+
 adducts ions as can be observed in Figure 7. A 500 µM aliquot of each DP series was 
dissolved in mQ water. Five µL of each DP series was mix with 20 µL of DHB matrix to a final 
concentration of 62.5 µM. Two µL of this mixture was spotted on a MALDI target plate and air-
dried for 5 min. Spots consisted in DHB matrix crystals at the surroundings and a uniform 
mixture in the middle. The instrument m/z range used was 300 to 1200 with 50 pulsations per 
laser shot and 38-50% laser intensity. Ions were suppressed below 300 Da. Malto-
oligosaccharides were found beside DHB matrix crystals.  
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Figure 7. Malto-oligosaccharides spectrum. DP3: Maltotriose hydrate (MW: 504.44 g/mol), 
DP4: maltotetraose (MW: 666.57 g/mol), maltopentaose (DP5, MW: 828.71 g/mol), 
maltohexose (DP6, MW: 990.85 g/mol). DP series formed Na
+
, K
+
 and rarely [M-H+ Na2]
+
 
adduct ions. AU: arbitrary units. 
 
A RL standard, containing a mixture of Rha-Rha-C10-C10 and Rha-C10-C10 congeners, 
was used as control and for training purposes. For MS/MS on RL congeners, MALDI-TOF/TOF 
ultraflex
III
 mass spectrometer (Bruker Daltonics) operated in lift mode for low molecular mass. 
Flexi Analysis and Compass Isotope Pattern software (Bruker Daltonics) were used for mass 
spectral analysis. RL peaks were assigned using an in silico database created according to the RL 
congeners reported in (37) with an 0.5 Da error mass. Molecular weight and expected adduct 
ions were calculated with Compass IsotopePattern. Lipids and di-lipids ranging from C8 to C16 
and one and two rhamnose sugars were also included in the database as K
+
 or Na
+ 
adduct ions, 
respectively. RL congeners formed M-Na
+
 and M-K
+
 and rarely [M-H+ Na2]
+
 adduct ions.  
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For tandem mass spectrometry of experimental samples an Agilent 1200 LC system coupled 
to an Agilent 6520A liquid chromatograph-quadrupole time-of-flight mass spectrometer (LC-Q-
TOF-MS) system (Agilent Technologies, Mississauga, ON, Canada) was used. A volume of 20 
µL of sample was injected into the LC system. LC separation was carried out on a Luna C18 
column (100 mm × 2.0 mm, 3 µm particle size) (Phenomenex Com., Torrance, CA, USA). LC 
mobile phases were (A) 5mM aqueous ammonium formate buffer at pH 3.3; (B) acetonitrile. The 
mobile phase flow rate was 0.3 mL/min. The gradient for LC system started at 5% B, increasing 
to 95% B in 15 min, and was held for 15 min. Afterwards, the mobile phase composition was 
returned to initial conditions and the column was allowed to equilibrate for 10min between runs. 
The electrospray ionization (ESI) interface was operated in negative mode and the capillary 
voltage was 4000 V. The fragmentor and skimmer voltages were 180 V and 80 V, respectively. 
Nitrogen was used as drying and nebulizing gas, and helium was used as the collision gas when 
the system was operated in MS/MS mode. The gas temperature was 350 °C, dry gas flow rate 
was 10 L/min and nebulizer pressure was 25 psi. Full-scan data acquisition was performed by 
scanning from m/z 50 to 1700. When operated in the MS/MS mode, the collision energy was 20 
eV. 
 
7.10. VISUALIZATION OF POLYHYDROXYALKANOATES LIPID GRANULES 
Transmission electron microscopy (TEM). Specimens were fixed with 2.5% 
glutaraldehyde and 0.1M calcium chloride in 0.1M sodium cacodylate buffer, pH 7.2 for a week, 
washed in 0.1M cacodylate buffer for 2 x 30 min, followed by postfixation with 1% (v/v) OsO4 
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in 0.1M cacodylate buffer for 1 hour. Cells were dehydrated in a graded ethanol series (30%, 
50%, 70%, 85%, 95%, 100%), substituted with propylene oxide, and embedded in LX112 epoxy 
resin. Ultrathin (60-80 nm) sections were obtained on an RMC Powertome ultramicrotome, 
double stained with uranyl acetate and lead citrate, viewed on a Hitachi HT7700 TEM at 100 kV 
and photographed with an AMT XR-41B 2k x 2k CCD camera. TEM images were taken at the 
microscopy facility in the Microbiology department, University of Hawai’i at Mānoa.  
 
7.11. CONSTRAINED DROP SURFACTOMETER ANALYSIS 
C3 cells in the culture were removed by centrifugation. The supernatant was dried at 
60ºC and the residues were resuspended in 0.1 mL of water. RL standard solutions were prepared 
by dissolving RL in MM. Both RL standard solutions and samples were sonicated for 3 min. An 
aliquot of 15 µL was placed onto a hydrophilic knife-sharp circular edge pedestal to form a 
droplet. After 30 s, the volume of the droplet was reduced to approximately 8.00 µL. The surface 
tension, surface area and droplet volume were calculated according to an axisymmetric drop 
shape analysis algorithm (103). At the beginning of the experiment, the pedestal was submerged 
in ethanol and sonicated for 10 min. The pedestal was cleaned with chloroform between 
measurements, and the instrument was calibrated with pure water to 72.8 mN/m. Experiments 
were done at Dr. Zuo’s laboratory in Engineering department, University of Hawai’i at Mānoa.  
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7.12. DATA CALCULATION.  
DBT degradation curves fitting. Time course points were drawn with standard errors of 
the mean (SEM) bars representing variation of 3 or 6 biological replicates. Degradation curves 
were fitted with a first-order kinetic equation, 𝑪 = 𝑪𝟎 × 𝒆
−𝒌𝒕 , where k is the DBT 
biodegradation rate constant and C is the concentration measured at time t. DBT half-life (𝒕𝟏/𝟐) 
was calculated with 𝒕𝟏/𝟐 =
𝒍𝒏 𝟐
𝒌
. Software OriginPro version 8.5 was used for graphing, fitting 
data points and calculating the degradation rate constant. 
 
 Statistical analysis. Multifactorial ANOVA with unequal sample sizes (n, 15 or 30) was 
used to calculate statistical significance (p, 0.001) using IBM SPSS Statistics 19 software. P-
value was set at 0.001 when the null hypothesis of homogeneity of variances was rejected. Least 
significant difference (LSD) and Tukey post-hoc tests were used for further exploration of the 
results. DBT degradation was used as the dependent factor. Incubation time, glycerol 
concentrations, type of inhibitor and concentrations used, RL fortification and initial inoculum 
were all set as fixed effects. Separate test were run depending upon fixed effects used.   
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8. CHAPTER 4: RESULTS 
8.1 HYPOTHESIS 1: GLYCEROL INDUCES ENHANCED COMETABOLISM OF 
DBT IN BURKHOLDERIA SP. C3 
 
8.1.1 Glycerol concentrations correlated with DBT cometabolism and C3 growth 
The effects of glycerol in DBT degradation by C3 were studied with HPLC. Figure 8 
shows chromatograms of 50 mM glycerol and 0.5 mM DBT biological triplicates extracted at 
day 1. The DBT concentration of triplicates was 0.335, 0.358 and 0.349 mM corresponding to 
retention times 20.492, 20.442 and 20.467, respectively. The retention times of ethyl acetate and 
DBT matched DBT standard shown in Figure 5.  
Figure 8. Chromatograms of extracts of triplicate C3 cell cultures supplemented with 50 
mM glycerol and 0.5 mM DBT at day 1. First and second peaks correspond to ethyl acetate 
and DBT, respectively.  
 
DBT degradation rates were quantified using different glycerol concentrations and in the 
presence of HEX or OC inhibitors. Generally, there was a small variation between biological 
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replicates as was observed in figures with small SEM values. The SEM using inhibitors was 
higher than without inhibitors.  
Glycerol enhanced DBT biodegradation while supporting bacterial growth, a 
phenomenon known as cometabolism (Figure 9). DBT as a sole carbon source did not support 
C3 growth. A 0.05 OD600 was observed after a 10-day incubation which was equal to that of the 
initial inoculum. DBT has no apparent benefit to the metabolizing bacteria.  
 
Figure 9. Enhanced DBT biodegradation induced by glycerol vs C3 growth. 
Concentrations of glycerol at 0.05, 0.5, 5, 50, 200 and 500 mM were used to give a DBT to 
glycerol molar ratio of 1:0.1, 1:1, 1:10, 1:100, 1:400 and 1:1000. Negligible degradation of DBT 
was observed in controls with autoclaved C3, but was not shown.  
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Glycerol-induced DBT cometabolism correlated with C3 growth. Interestingly, C3 
growth in DBT-glycerol mixtures was inhibited when compared to glycerol alone. Growth rates 
varied with the glycerol concentration used and incubation time. For example, mixtures of 0.5 
mM DBT with glycerol ranging from 50 to 500 mM exhibited reduced growth as much as 0.3 
OD600 relative to glycerol alone. DBT did not inhibit growth at lower concentrations of glycerol 
(0.05-5 mM). An increased in C3 growth using high concentrations of glycerol relative to DBT 
was observed starting at day 4. It is possible that more DBT may be co-absorbed with glycerol. 
Therefore, such growth inhibition with 50 to 500 mM glycerol concentrations may be associated 
to either DBT and DBT metabolites toxicity or both.  
Enhanced DBT biodegradation was dependent upon glycerol to DBT ratio and incubation 
time. Glycerol to DBT molar ratios at 1:1, 10:1, 100:1 and 400:1 (0.5, 5, 50 and 200 mM of 
glycerol, respectively) enhanced DBT cometabolism by 25-30% after 1 day of incubation. C3 
degraded 92% of 0.5 mM DBT at day 10 in cultures containing 0.5 mM glycerol. However, at 
this glycerol concentration C3 growth remained at 0.05 OD600. Evidencing that increased 
biomass was not the only cause for the enhanced DBT cometabolism. Glycerol (0.05 mM) at a 
molar ratio of 0.1:1 to DBT did not show enhancement of DBT degradation in C3 at day 1 and 4 
of incubation; whereas at day 7 and 10, it enhanced DBT biodegradation by 25-30% relative to 
no addition of glycerol (Figure 9). In cultures at 100:1 glycerol (50 mM) to DBT molar ratio, C3 
degraded 100% of 0.5 mM (100 ppm) DBT after 7 days of incubation. This optimal glycerol 
concentration was utilized during the remainder of experiments. Dose dependent effects of 
glycerol on the degradation rate constant and DBT half-life are shown in Table 5. DBT half-life 
decreased from 27.5 to 1.5 days in cultures containing glycerol. Similarly, up to 18-fold increase 
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in the DBT degradation rate constant was observed at glycerol to DBT molar ratios of 0.1:1, 1:1, 
10: 1, 100:1, 400:1 and 1000:1. Negligible DBT degradation was observed using cultures with 
autoclaved bacteria as controls. 
 
Table 5. Enhancement of DBT biodegradation rate constant and DBT half-life is 
dependent on glycerol concentration. Exponential decay equation, 𝐶 = 𝐶0  ×  𝑒
−𝑘𝑡 was used 
for fitting “N” data points where k is rate constant and t is time in day. *Relative to rate constant 
of 0.5 mM DBT. 
Substrate 
Rate constant 
(Days
-1
) R
2
 
Half-life 
(Days) N Fold change* 
0.5 mM DBT 0.025±0.01 0.63 27.5 30 0.0 
0.05 mM glycerol & 0.5 mM DBT 0.064±0.01 0.84 10.8 15 1.6 
0.5 mM glycerol & 0.5 mM DBT 0.359±0.09 0.90 1.9 15 13.2 
5 mM glycerol & 0.5 mM DBT 0.390±0.05 0.99 1.8 15 14.5 
50 mM glycerol & 0.5 mM DBT 0.479±0.02 0.99 1.5 30 18.0 
200 mM glycerol &0.5 mM  DBT 0.229±0.02 0.99 3.0 15 8.1 
500 mM glycerol & 0.5 mM DBT 0.113±0.00 1.00 6.1 15 3.5 
0.5 mM DBT (autoclaved C3) 0.002±0.01 0.31 287.6 27 -0.9 
50 mM glycerol & 0.5 mM DBT 
(autoclaved C3) 
0.009±0.00 0.99 70.44 15 -0.6 
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8.1.2. Proteins involved in DBT degradation in C3 
The proteins involved in DBT degradation identified through LC-MS in C3 are shown in 
Table 6. Interestingly, the majority of these proteins were also found in C3 containing only 50 
mM glycerol. The results indicated that glycerol alone can induce the expression of proteins 
involved with degradation of DBT and other PAHs. 
 
Table 6. Proteins involved in of degradation of xenobiotics identified in C3. NO: Not 
observed. Treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; C, 50 mM glycerol and 0.5 
mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. Proteins were extracted at day 2. 
Three biological replicates were analyzed in each treatment. Mean normalized value is shown in 
each treatment. The LogFC represents the glycerol*DBT interaction term. *The relative 
abundance among treatment showed significant differences (p-value<0.05). 
  
Relative abundance by 
Treatment 
  
UniProt ID Description A B C D LogFC P-value 
G5L3J5 Hydratase aldolase (DbtE)* 1.98 1.27 2.33 2.40 1.97 0.000 
Q93CN9 Extradiol dioxygenase (DbtC) 1.82 0.96 1.43 1.91 0.32 0.576 
Q93CN7 Putative monooxygenase α- 
subunit 
2.02 1.62 2.02 1.87 0.41 0.421 
Q93NA7 Dioxygenase β- subunit 
(DbtAd)* 
1.83 NO 1.83 2.30 2.01 0.001 
Q93NA6 Dihydrodiol dehydrogenase 
(DbtB) 
1.63 0.88 1.28 1.35 -0.11 0.857 
Q93CN6 Putative hydrolase 0.97 1.09 0.93 1.30 -0.02 0.973 
Q93NA8 Dioxygenase α- subunit 
(DbtAc) 
1.59 1.00 1.44 1.60 0.12 0.837 
C7DQZ5 Dehydrogenase (PhnF) 1.03 1.08 1.23 0.74 -0.47 0.400 
51 
 
Table 6 (continued). Proteins involved in degradation of xenobiotics identified in C3. 
NO: Not observed. Treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; C, 50 mM glycerol 
and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. Proteins were extracted at 
day 2. Three biological replicates were analyzed in each treatment. Mean normalized value is 
shown in each treatment. The LogFC represents the glycerol*DBT interaction term. *The 
relative abundance among treatment showed significant differences (p-value<0.05). 
  Relative abundance by treatment  
UniProt ID Description A B C D LogFC P-value 
C7DQY7 Cis-naphthalene dihydrodiol 
dehydrogenase (NahB) 
1.49 1.64 1.46 1.13 -0.98 0.095 
C7DQY6* PAH dioxygenase small 
subunit 
1.45 1.40 1.12 0.92 -1.28 0.036 
C7DQY8 Salicylaldehyde 
dehydrogenase (NagF) 
1.38 1.24 1.82 1.96 -2.41 0.066 
C7DQY1 Ferredoxin reductase (NagAa) 1.32 1.36 1.36 1.34 -0.17 0.762 
C7DQZ1 Gentisate-1,2-dioxygenase 
(NagI)  
1.40 1.09 1.12 1.20 -0.08 0.903 
C7DR01 Dihydrodiol dehydrogenase 
(PhnB) 
1.17 1.06 1.13 0.82 -0.50 0.448 
C7DQZ7 Extradiol dioxygenase (PhnC) 1.34 0.95 1.38 1.20 0.34 0.577 
C7DQY5 PAH dioxygenase large 
subunit 
1.31 0.76 1.30 1.10 0.41 0.503 
C7DQZ3 Salicylate-5-hydroxylase large 
oxygenase component (NagG) 
NO 1.01 1.29 0.69 0.53 0.431 
C7DQZ6 Hydratase/aldolase (PhnE) NO 0.75 1.19 1.30 0.88 0.205 
C7DQY9 1,2-Dihydroxynaphthalene 
dioxygenase (NahC) 
1.23 NO NO 1.24 -0.72 0.328 
C7DQZ2 Fumarylacetoacetate hydrolase 0.72 0.79 0.70 0.53 -0.27 0.729 
C7DQZ0 Reductase component of 
salicylate-5-hydroxylase 
(NdsA) 
1.02 0.75 1.05 0.41 -0.09 0.899 
C7DQZ7 Extradiol dioxygenase (PhnC) 1.34 0.95 1.38 1.20 0.34 0.577 
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Table 6 (continued). Proteins involved in degradation of xenobiotics identified in C3. 
NO: Not observed. Treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; C, 50 mM glycerol 
and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. Proteins were extracted at 
day 2. Three biological replicates were analyzed in each treatment. Mean normalized value is 
shown in each treatment. The LogFC represents the glycerol*DBT interaction term. *The 
relative abundance among treatment showed significant differences (p-value<0.05). 
  Relative abundance by treatment  
UniProt ID Description A B C D LogFC P-value 
C7DQY5 PAH dioxygenase large 
subunit 
1.31 0.76 1.30 1.10 0.41 0.503 
C7DQZ3 Salicylate-5-hydroxylase large 
oxygenase component (NagG) 
NO 1.01 1.29 0.69 0.53 0.431 
C7DQZ6 Hydratase/aldolase (PhnE) NO 0.75 1.19 1.30 0.88 0.205 
C7DQY9 1,2-Dihydroxynaphthalene 
dioxygenase (NahC) 
1.23 NO NO 1.24 -0.72 0.328 
C7DQZ2 Fumarylacetoacetate hydrolase 0.72 0.79 0.70 0.53 -0.27 0.729 
C7DQZ0 Reductase component of 
salicylate-5-hydroxylase 
(NdsA) 
1.02 0.75 1.05 0.41 -0.09 0.899 
C7DR00 Dioxygenase β-subunit 
(PhnAd) 
NO 0.60 NO NO -1.01 0.289 
C7DQZ8 Isomerase (PhnD) 0.23 NO 0.44 0.53 1.04 0.415 
R9W162 Aromatic-ring-hydroxylating 
dioxygenase* 
1.73 0.42 1.58 2.17 1.39 0.033 
A0A0M4NP56 Naphthalene-1,2-dioxygenase*  1.68 NO 1.66 1.76 1.26 0.044 
A0A0D5VFY1 Glycerol-3-phosphate 
dehydrogenase (GlpD)* 
NO 1.07 1.94 NO 1.76 0.003 
A0A0D5V9F3 sn-glycerol-3-phosphate 
import ATP-binding (UgpC) 
NO 0.51 0.82 NO 0.32 0.729 
A0A0D5VFT7 Glycerol Kinase (GlpK) NO 1.54 1.46 NO -0.24 0.648 
A0A0D5VC54 Glycerate kinase NO 0.86 0.46 NO -1.22 0.201 
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Proteins expressed by C3 during phenanthrene and naphthalene degradation (35) were 
also observed when exposed to DBT. The presence of proteins involved in naphthalene 
degradation suggested that after the first aromatic ring is removed from DBT, degradation 
subsequently follows naphthalene metabolic pathway. Similarly, identification of phenanthrene 
(C7DR00) and naphthalene (A0A0M4NP56) dioxygenase subunits suggested broad enzyme 
specificity towards DBT degradation and this was independent of glycerol supplementation..  
Interestingly, a set of proteins specifically involved in DBT degradation was identified 
for first time in C3 and the putative catalytic steps are shown in Figure 10. These proteins were 
initially reported on Burkholderia fungorum sp. DBT1. In the study, DbtAc and DbtC insertional 
DBT1 mutants lost their capacity to metabolize DBT (59). The identified enzymes suggest that 
C3 degrades DBT through lateral dioxygenation pathway.  
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Figure 10. Putative steps catalyzed by DBT degradative enzymes identified in C3. 
Enzymes: DbtAc, DBT dioxygenase α subunit; DbtAd, DBT dioxygenase β subunit; DbtB, 
Dihydrodiol dehydrogenase; DbtC, Extradiol dioxygenase; DbtD, isomerase; DbtE: hydratase-
aldolase.  
 
Regarding glycerol utilization, at day 2 GlpD (A0A0D5VFY1) is significantly up-
regulated (p-value<0.005) in comparison to GlpK (A0A0D5VFT7), which suggests that most of 
the glycerol has been assimilated as glycerol-3-phosphate. The presence of G3P transporters 
supports this indication. C3 can also assimilate glycerol as glycerate-3-phosphate by glycerate 
kinase (A0A0D5VC54). The absence or low abundance of these proteins in treatment D 
indicated that OC inhibited initial glycerol assimilation in C3. 
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8.2 HYPOTHESIS 2: GLYCEROL STIMULATES THE SYNTHESIS OF PROTEINS 
THAT MEDIATE LIPID METABOLIC PATHWAYS 
 
8.2.1. Inhibition of -oxidation of fatty acids decreased DBT biodegradation and C3 
growth 
HEX and OC strongly inhibited C3 growth and DBT degradation. At 2 mM, inhibition of 
DBT degradation was greater with HEX than with OC before 4 days of incubation. Interestingly, 
unlike C3 growth, the DBT biodegradation ability of C3 was restored at 7-10 days of incubation 
(Figure 11). At this inhibitor concentration, the rate constant decreased from 0.479 to 0.324 day
-1
 
with HEX and to 0.375 day
-1
 with OC (Table 7). 
At 5 mM, OC had greatly inhibited DBT degradation in comparison to HEX. In terms of 
cell growth, C3 reached 0.2 OD600 at both 2 mM and 5 mM OC concentrations, but 5 mM had a 
greater negative effect on DBT degradation. In cultures with HEX, C3 reached 0.5 OD600 at 5 
mM, whereas at 2 mM, C3 only reached 0.2 OD600. Opposite results were obtained on DBT 
degradation; a 5 mM HEX concentration had a greater inhibitory effect than a 2 mM. The 
observations suggested that glycerol enhanced cometabolism is the results of several metabolic 
mechanisms and not only those involved with enhanced growth. At 5 mM, rate constants 
decreased from 0.479 to 0.162 day
-1 
with HEX and to 0.033 day
-1 
with OC (Table 7).  
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Figure 11. HEX and OC lipid pathways inhibitors decreased DBT biodegradation 
and C3 growth. All curves were tested with a 50 mM glycerol concentration. The final 
concentration of 2-bromohexanoic acid (HEX) and 2-bromooctanoic acid (OC) were at 2 mM or 
5 mM. An exponential decay equation,  𝑪 = 𝑪𝟎  ×  𝒆
−𝒌𝒕 , was used for fitting data points of 
degradation curves. Error bars represent variation among 3 or 6 samples. Inhibitors concentration 
significantly affected DBT degradation (p-value<0.001). 
 
HEX and OC inhibited bacterial growth in cultures supplemented with glycerol alone. C3 
reached 0.3 OD600 when cultured with 50 mM glycerol and 2 mM or 5 mM HEX. In cultures 
with 50 mM glycerol and 2 mM or 5 mM OC, C3 reached 0.35 OD600 at 4 days. HEX had 
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slightly greater effects on bacterial growth than OC. Thus, OC was used for proteome profiling 
experiments. Additionally at 2 mM, HEX and OC had similar effects on bacterial growth in 
cultures containing DBT in addition to glycerol. For both inhibitors, C3 reached 0.2 OD600 at the 
end of the incubation period. Thus, this concentration was used during the remainder of the 
experiments. 
 
Table 7. Influence of bromoalkanoic acid inhibitors in DBT biodegradation rate 
constant and DBT half-life. Exponential decay equation, C = C0 ×  e
−kt was used for fitting 
“N” data points where k is rate constant and t is time in day. *Relative to rate constant of 0.5 mM 
DBT. 
Treatment 
Rate constant 
(Day-1) 
R
2
 Half-life 
(Day) 
N Fold 
change* 
0.5 mM DBT 0.025±0.01 0.63 27.5 30 0.0 
50 mM glycerol & 0.5 mM DBT 0.479±0.02 0.99 1.6 30 18.0 
2 mM HEX & 50 mM glycerol & 0.5 mM DBT 0.324±0.00 1.00 2.14 15 11.8 
2 mM OC & 50 mM glycerol & 0.5 mM DBT 0.374±0.03 0.97 1.9 30 13.8 
5 mM HEX & 50 mM glycerol & 0.5 mM DBT 0.162±0.05 0.88 4.28 15 5.4 
5 mM OC & 50 mM glycerol & 0.5 mM DBT 0.032±0.00 0.98 21.45 15 0.3 
 
DBT biodegradation kinetics experiments showed that the inhibitory effects were 
dependent upon the concentration used and the inhibitor (Figure 11). This was investigated with 
a multifactorial ANOVA followed by post-hoc tests. Type of inhibitor (OC, HEX or without; 3 
levels), concentration (0, 2 or 5 mM; 3 levels) and incubation time (5 levels) were used as fixed 
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factors. Inhibitor suppressed DBT biodegradation by 15%. Chain-length specificity of inhibitor 
was not a significant factor. The concentration used (either 2 or 5 mM) had a 42% significant 
effect on DBT degradation (multifactorial ANOVA p-value <0.001). Regarding incubation time, 
pairwise comparison showed that incubating for 7 days or 10 days did not make a significant 
difference (p-value =0.831). All other pairwise comparisons were significant (p-value <0.001).  
 
8.2.2. Up-regulated proteome: DBT metabolism versus glycerol induced DBT 
cometabolism 
In order to determine additional mechanisms induced by glycerol, the C3 proteome was 
profiled under 4 different treatments. The treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; 
C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. 
Proteomes correlation plot ( 
 Figure 12) showed that the relative abundance of proteins detected in C3 grown 
using DBT (treatment A) were more correlated with proteins detected in C3 grown with 
glycerol/DBT treated with OC (treatment D). Similarly, the relative abundance of proteins 
identified in C3 grown using glycerol (treatment B) correlated better with proteins from glycerol 
with DBT (treatment C) than any other treatment. There was also correlation between treatments 
C and D. Small variation between biological replicates was also observed.  
59 
 
 
 Figure 12. Correlation plot of the relative abundance of proteins extracted from C3 
grown under different treatments. A total of 1935 proteins were used for plotting. Proteins 
were extracted at day 2. Treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; C, 50 mM 
glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. Biological 
replicates are 1, 2 and 3. 
 
The same correlation between treatments was observed in proteins with significant 
changes in relative abundance (P-value <0.05, Figure 13). The changes in relative abundance of 
proteins extracted from cells treated with OC inhibitor (treatment D) had higher similarity to 
proteins extracted from cells grown with DBT (treatment A). The analysis shown in Table 6 
supported these findings. OC inhibitor is suppressing glycerol assimilation at the proteomic level, 
and thus this correlation.  
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 Figure 13. Heat map of significant changes in the relative protein abundance in 
correspondence with treatments. Plot shows the relative abundance of 122 proteins (p-value < 
0.05). Proteins were extracted at day 2. Treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; 
C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. Mean 
values of normalized values were used. 
 
Many of the proteins depicted in Figure 13 were related to protein translation and proper 
folding cell processes. For example, 3 50S (B1JU41, B5WTF5 and A0A0D5V6G6) ribosomal 
subunits, RNA polymerase sigma factor RpoD (A0A0D5VLP3) and RNA polymerase-binding 
transcription factor DksA (A0A0D5VEZ5) were detected and showed significant upregulated 
LogFC. Protein synthesis and correct folding are cellular mechanisms in response to a chemical 
stress (104).  
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Similarly, chaperones DnaK (A0A0D5VFX6) and HtpG (A0A0D5V7V8) and elongation 
factor G (A0A0D5VCE6) were detected and the LogFC was down-regulated, denoting these 
proteins were not important for cellular processes when the cells were exposed to DBT and 
Glycerol. However, down-regulation of the LogFC value does imply the presence of these 
proteins in cells exposed to DBT alone or glycerol alone and hence the importance of comparing 
the different treatments. Arginine-tRNA ligase (A0A0D5VB61), Aspartate-tRNA ligase 
(A0A0D5VFE6), Glycine-tRNA ligase beta subunit (A0A0D5VAC2), Isoleucine-tRNA ligase 
(A0A0D5VEQ0) and Threonine-tRNA ligase (A0A0D5V9J4), also were significantly down 
regulated. These proteins involved in protein biosynthesis were abundant in cells exposed to 
glycerol. Figure 9 evidenced that C3 is more metabolically active and reached a higher OD600 
with glycerol alone, which would explained the higher abundance of these proteins in treatment 
B. 
Tautomerase (A0A0M3TVK8) a protein involved in cellular metabolism of aromatic 
compounds (GO:0006725) was significantly up-regulated. In Pseudomonas stutzeri, this protein 
is part of the salicylate metabolic pathway. Additionally, FMN-dependent NADH-azoreductase 
(A0A0D5V7V5) involved in reductive cleavage of aromatic azo compounds was also 
significantly up-regulated. Along with a putative monoxygenase alpha subunit (Q93CN7), 
naphthalene 1,2-dioxygenase (A0A0M4NP56) and 2,3-dihydroxy-2,3-dihydrophenylpropionate 
dehydrogenase (Q93NA6). These results agreed with the ones from Table 6, both suggest that 
glycerol induces the expression of proteins involved in xenobiotic degradation.  
The LogFC of enzymes poly(R)-hydroxyalkanoic acid synthase (A0A0Q5H1G7) and 
poly(R)-hydroxyalkanoic acid synthase, class I (A9BZX2 and W6X074) were significantly up-
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regulated. These enzymes are involved in the production of PHA for granule formation (105). 
The regulation of these enzymes suggested that lipid metabolism is stimulated by glycerol. 
Hence, lipid metabolic pathways were investigated more in depth in the next sub-chapter. 
Additional proteins with general (e.g. aldolase) and uncharacterized functions (9 proteins) 
were also significant. The full list of proteins that showed significant changes in relative 
abundance among treatments is found in the Annexed (Table 13). 
 
8.2.3. Proteins involved in -oxidation and FAS II pathways from C3 were up-
regulated in the presence of glycerol 
Glycerol assimilation can affect lipid metabolic pathways. The proteins found in C3 
related to lipid metabolism are shown in Table 8. Proteins involved in FAS II and β-oxidation 
pathways were identified in all treatments (A, B, C and D). FabG is a key enzyme in R-3-
hydroxydecanoyl-ACP synthesis via FAS II pathway (73). The relative abundance of FabG was 
>1 in all treatments. The preceding step catalyzed by FabF was up-regulated with glycerol, 
however, these up-regulation was not statistically significant. FadE from β-oxidation was up-
regulated and the p-value was 0.089. The evidence suggests that both FAS II and β-oxidation 
pathways were active in C3.  
 
 
 
63 
 
Table 8. Proteins involved in lipid metabolic pathways and PHA formation. ACP: 
acyl carrier protein. NO: Not observed. Treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; 
C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. Proteins 
were extracted at day 2. Three biological replicates were analyzed in each treatment. Mean 
normalized value is shown in each treatment. The LogFC represents the glycerol*DBT 
interaction term. *The relative abundance among treatment showed significant differences (p-
value<0.05). 
  Relative abundance by 
treatment 
  
UniProt ID Protein description A B C D LogFC P-value 
Q63S87 β-oxoacyl-ACP synthesis 
(FabF) 
NO 0.62 1.38 NO 0.78 0.235 
A0A0D5VAR9 3-oxoacyl-ACP-reductase 
(FabG) 
1.32 1.06 1.36 1.45 -0.58 0.328 
A0A0D5VAC6 3-hydroxy -ACP-dehydratase 
(FabZ) 
0.98 NO NO 1.10 1.39 0.140 
K8R0G3 Acyl-CoA dehydrogenase 
(FadE) 
NO NO 0.69 NO 1.99 0.089 
Q3JVY2 Enoyl-CoA hydratase/3- 
hydroxyacyl-CoA 
dehydrogenase (FadB) 
NO 1.15 1.14 NO -0.20 0.768 
A0A0Q5H1G7 Poly(R)-hydroxyalkanoic acid 
synthase* 
0.23 0.00 0.83 0.80 2.77 0.011 
W6X074 Poly(R)-hydroxyalkanoic acid 
synthase, class I* 
0.41 0.00 0.54 0.95 2.09 0.043 
A9BZX2 Poly(R)-hydroxyalkanoic acid 
synthase, class I* 
0.00 0.13 0.83 0.80 2.51 0.017 
D8P4I5 Poly-beta-hydroxybutyrate 
polymerase 
0.23 0.37 0.49 1.05 1.62 0.077 
A0A0D5VF95 Cyclopropane-fatty-acyl-
phospholipid synthase 
NO 0.95 1.52 0.26 0.58 0.338 
A0A0N1KL01 Phasin family protein* 2.03 2.13 2.26 1.96 -1.34 0.005 
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Table 8 (continued). Proteins involved in lipid metabolic pathways and PHA 
formation. ACP: acyl carrier protein. NO: Not observed. Treatments were: A, 0.5 mM DBT; B, 
50 mM glycerol; C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 
mM OC. Proteins were extracted at day 2. Three biological replicates were analyzed in each 
treatment. Mean normalized value is shown in each treatment. The LogFC represents the 
glycerol*DBT interaction term. *The relative abundance among treatment showed significant 
differences (p-value<0.05). 
  Relative abundance by 
treatment 
  
UniProt ID Description A B C D LogFC P-value 
A0A0D5VHK5 Phasin family domain protein NO 1.57 1.78 0.80 0.46 0.443 
I7A5Y0 PHA synthesis regulatory 
protein (PhaR) 
0.94 0.42 0.46 0.26 -1.01 0.281 
A0A0D5VCV0 Phosphatidylethanolamine-
binding family protein* 
0.23 0.66 0.96 1.24 2.01 0.030 
 
The relative abundance of phasin and Poly(R)-hydroxyalkanoic acid synthase proteins (Table 
8) suggested that C3 may be forming PHA granules in cultures with glycerol. PHA granule 
formation is widely suggested for lipid storage when a high concentration of carbon source is 
provided (73). Interestingly, phasin A0A0N1KL01 was also found in cells grown with DBT alone, 
which suggested that PHA lipid synthesis and possible granule formation may be an additional 
mechanism in enhanced DBT degradation.  
Cyclopropane-fatty-acyl-phospholipid synthase (A0A0D5VF95) is involved in formation 
of cyclopropane membrane fatty from S-adenosyl-L-methionine and phospholipid olefinic fatty 
acid. S-adenosyl-L-methionine-dependent methyltransferase (A0A0D5VPL5) was also up-
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regulated (LogFC = 0.82). This enzyme utilizes S-adenosyl-L-methionine to methylate proteins, 
small molecules, nucleic acids and lipids (108, 109).  
 
8.2.4. PHA granule formation is induced by glycerol in C3 
PHA synthases were identified in the 4 treatments (Table 11). These proteins bound to 
the surface of PHA granules, catalyzing its formation and aggregation. Similarly, phasin proteins 
were up-regulated in cultures supplemented with 50 mM glycerol. Phasins attach to PHA 
granules (105) and a role in determination of PHA volume-to-surface ratio (105) and granule 
stabilization (76) was proposed. Proteome profiling suggested that glycerol induced C3 to 
synthesize PHA granules. TEM images of C3 taken at 2 or 7 days of incubation with 0.5 mM 
DBT with or without 50 mM glycerol were acquired for PHA granule visualization (Figure 14). 
Glycerol induced PHA lipid granule formation inside C3 cell at 2 days of incubation. PHA 
granules were not seen in cells cultured with DBT alone at day 2. After 7 days of incubation 
PHA granule formation induced by glycerol was more prominent. Interestingly, there were C3 
cells cultured with DBT alone that after 7 days of incubation showed PHA granules, but this was 
not the overall culture. Proteomics data also supported this evidence (Table 8). A clear separation 
between DBT and C3 cell membrane was observed, evidencing either exopolysaccharide 
secretion or chemical interactions between DBT and C3.  
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Figure 14. Glycerol induced PHA granules formation in C3. Cells were incubated 
with 0.5 mM DBT with or without 50 mM glycerol. Cell membrane vesicle detachment is shown 
by arrow. DBT crystals can be observed surrounding C3 cells. Images were taken at day 2 or 7 of 
incubation. PHA vesicles were between 100-200 nm in diameter. 
 
Cell membrane detachment of vesicles was also observed and was more noticeable in C3 
cells cultured with DBT as the only carbon source. (Figure 14, indicated by arrow). PHA 
granules are showed as white rounded structures of 100–200 nm in diameter. TEM sample 
preparation involves the fixing of cells into a solid support from which cross sections are cut, 
limiting the amount of information that can be obtained, including the PHA granules size range. 
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However, the trend was that smaller granules were observed at the earlier stage of incubation 
(Day 2), whereas, bigger ones were observed at the later stage of incubation (Day 7). 
 
Figure 15. HEX and OC inhibited the formation of PHA granules in C3 at 2 days of 
incubation. Cells were incubated with 0.5 mM DBT and 50 mM glycerol. HEX or OC inhibitors 
were added at 2 mM final concentration. DBT crystals can be observed surrounding C3 cells. 
Images were taken at day 2 or 7 of incubation. PHA vesicles were between 100-200 nm in 
diameter. 
 
It was shown that HEX and OC negatively affected DBT degradation. Phasin protein 
profiling suggested that OC inhibited PHA lipid granule formation. The use of HEX and OC was 
investigated for PHA granule formation inhibition. It was expected that at early stages (Day 2), 
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HEX and OC will inhibit granule formation and that at day 7 the ability in C3 would be restored. 
The results shown in Figure 15 agreed with the expectations. PHA lipid formation was inhibited 
at day 2 and restored at day 7 with both HEX and OC inhibitors. According to the kinetics 
analysis shown in Figure 11, there is a strong association between DBT degradation and PHA 
granule accumulation in C3. 
 
8.3. HYPOTHESIS 3: GLYCEROL INDUCES LIPID PRECURSOR SUPPLY FOR 
BIOSYNTHESIS OF RL BIOSURFACTANT  
 
8.3.1 Identification of genes confirmed the potential of RL biosynthesis in C3  
We observed that DBT-glycerol cultures exhibited foam formation (data not shown), 
suggesting the possible secretion of a biosurfactant. Glycerol can readily enter into FAS II and β-
oxidation pathways and these pathways were active in C3 under all the conditions tested (Table 
8; Treatments A, B, C and D).  
Our protein profiling and TEM results showed that PHA vesicle formation was induced 
in cultures with glycerol and DBT. PHA and RL molecules share the lipid precursor obtained 
from either or both FAS II or β-oxidation for their biosynthesis (Figure 4). Accordingly, the 
genes involved in RL biosynthesis in C3 were investigated to confirm the potential ability of C3 
for RL secretion.  
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Table 9. C3 rhlABC genes homology to other Burkholderia species. bp: basepair. 
BLASTP algorithm and UniProt database were used to find sequence homology. 
UniProt ID Protein name Organism Identity 
(%) 
Query 
length 
(bp) 
H8WGC8 Rhamnosyltransferase 1, subunit A B. glumae 78.4 1009 
A0A0D5VKY2 Isoprenylcysteine carboxyl 
methyltransferase 
B. fungorum 99.3 450 
C4I4U9 Rhamnosyltransferase I, subunit B B. pseudomallei MSHR3446 99.8 1131 
A0A135HB09 MFS transporter B. thailandensis 64.5 107 
Q3JLM3 Rhamnosyltransferase I subunit C B. pseudomallei 72.3 298 
 
Primers were designed to target conserved regions of 13 rhlB sequences from 
Burkholderia species. A DNA sequence (280 bp) matching Rhamnosyltransferase I subunit B 
from Burkholderia pseudomallei (99.8% identity) was obtained. This sequence was used to 
design inverse PCR primers. The full self-ligated plasmid was 3284 bp. A search for bacterial 
operons identified 3 ORFs located on the positive plasmid strand. These ORFs were determined 
to be the rhlA, rhlB and isoprenylcysteine carboxyl methyltransferase genes (
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Table 9). Further analysis showed a 4
th
 gene to be the MFS transporter, which was partially 
sequenced.  
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Figure 16. Cluster of rhlABC genes in C3 involved in RL synthesis. Solid line arrows 
represent genes fully sequenced. Dashed line arrows represent genes partially sequenced. 
Burkholderia database was used to find gene cluster homology to other Burkholderia species. 
 
The gene rhlC (298 bp) was not found in the self-ligated plasmid and was obtained using 
degenerate primers instead. Comparisons of the gene cluster to those of Burkholderia species 
suggested the rhlABC gene cluster proposed in Figure 16. 
 
8.3.2 RL fortification and enhanced DBT biodegradation 
In addition to rhlABC genes to further test the effects of RLs on DBT degradation, 20 
µg/mL of a mixture of two RL congeners (Rha-Rha-C10-C10 and Rha-C10-C10) was added to 
cultures at 0.05 and 0.2 inocula (OD600) containing 0.5 mM DBT (100 ppm). RL congeners did 
not support bacterial growth.  Furthermore, addition of RL congeners dispersed DBT aggregates 
normally found at the surface of liquid cultures generating many small precipitates. It is possible 
that the increased biodegradation rates shown in Table 10 are the result of pseudomicelle 
formation, increasing the DBT contact surface area and thus DBT toxicity to the bacterial cells. 
This may explain the decreased on OD600 at day 1(Figure 17). 
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Figure 17. RL fortified enhanced DBT biodegradation. Twenty µg/mL of RL (solid 
symbols) was added into C3 inocula at 0.2 OD600. An exponential decay equation, 𝑪 =
𝑪𝟎 ×  𝒆
−𝒌𝒕, was used for fitting data points of degradation curves. Inset: semi ln fitting.  
 
A multifactorial analysis with incubation time, RLs fortification and inoculum as fixed 
factors showed that incubation time and RLs were significant factors (p-value< 0.001) 
accounting for 49% and 37%, respectively (Figure 17). 
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Table 10. Influence of RL fortification and C3 density in DBT biodegradation rate 
constant and DBT half-life. The final RL concentration was 20 µg/mL. Exponential decay 
equation, 𝐶 = 𝐶0 × 𝑒
−𝑘𝑡, was used for fitting “N” data points where k is rate constant and t is 
time in day. Relative to rate constant of 0.5 mM DBT with * 0.05 OD600 C3 inoculum and ** 0.2 
OD600 C3 inoculum. 
Treatment 
Rate constant 
(Day
-1
) 
R
2
 Half-life 
(Day) 
N Fold 
change 
0.5 mM DBT (0.05 OD600 C3 inoculum) 0.025±0.01 0.63 27.5 30 0.0 
0.5 mM DBT with RL (0.05 OD600 C3 inoculum) 0.053±0.01 0.91 14.0 30 1.1* 
0.5 mM DBT (0.2 OD600 C3 inoculum) 0.047±0.00 0.98 15.8 15 0.7* 
0.5 mM DBT with RL (0.2 OD600 C3 inoculum) 0.133±0.01 0.95 5.2 30 1.8** 
 
The RL mixture fortified at 20 µg/mL increased the DBT biodegradation rate constant at 
both OD600 0.05 and 0.2 cultures (from 0.025 to 0.053 day
-1
 and from 0.047 to 0.133 day
-1
, 
respectively) as shown in Table 10.  
 
8.3.3. RL biosynthesis induced by glycerol enhances DBT biodegradation in C3 
RLs are amphipathic molecules with surface tension reduction properties. They are 
glycolipids with 1 or 2 rhamnose sugars attached (37). An orcinol assay is commonly used to 
measure the levels of RLs (via rhamnose sugar) (110). RL biosynthesis and secretion, induced by 
varying concentrations of glycerol, associated well with the amount of DBT degraded (Figure 
18A). Surface tension measurements further confirmed the biosurfactant production (Figure 
18B). The DBT-glycerol cultures achieved 48-51 mN/m surface tension in comparison with 60-
65 mN/m of the DBT cultures and with 55-62 mN/m of the glycerol cultures over the time 
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course. A greater reduction in surface tension relates to a higher biosurfactant concentration until 
the critical micelle concentration (CMC) is reached (31). 
 
Figure 18. Relationship between DBT biodegradation and RL secretion induced by 
glycerol in C3 (A) and tensioactive properties of the cultures (B). Concentrations of DBT in 
the culture media were measured after 24 hours. RLs were extracted from a cell free 5 mL 
culture after 2 days of incubation. Reference surface tension of water: 72.8 mN/m. 
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It has been reported that 2-bromoalkanoic acids (HEX and OC) inhibit RL biosynthesis 
(64, 65). If RLs secreted by C3 play a role in DBT biodegradation, HEX and OC should decrease 
DBT biodegradation via RL biosynthesis inhibition.  
 
Figure 19. Relationship between the inhibition of RL biosynthesis by HEX or OC 
acid (A) and DBT biodegradation (B). 2-Bromohexanoic acid (HEX) and 2-bromooctanoic 
acid (OC) were at 2 mM final concentration. (A) DBT biodegradation cultures were treated with 
either HEX or OC inhibitors for 24 hours. (B) RLs were extracted from a cell free 5 mL culture 
after 2 days of incubation.  
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The results shown in Figure 19 evidenced that the decrease in RL biosynthesis by HEX 
and OC inhibition was strongly associated with decreased DBT degradation ability in C3. 
 
8.3.4. The proteins involved in RL synthesis were identified 
Table 11. Proteins mediating RL synthesis in C3. NO: Not observed. Treatments were: 
A, 0.5 mM DBT; B, 50 mM glycerol; C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 
0.5 mM DBT and 2 mM OC. Proteins were extracted at day 2. Three biological replicates were 
analyzed in each treatment. Mean normalized value is shown in each treatment. The LogFC 
represents the glycerol*DBT interaction term. *The relative abundance among treatment showed 
significant differences (p-value<0.05). 
  Relative abundance by 
treatment 
  
UniProt ID Protein description A B C D LogFC P-value 
U1XYV8 HAA synthase (RhlA) 0.85 NO 0.86 1.09 1.52 0.090 
A0A0B6RU44 Rhamnosyltransferase 1 (RhlB) 1.46 1.02 NO 1.28 -0.57 0.407 
C4I4U9 Rhamnosyltransferase 1 
(RhlB) 
0.85 0.81 NO 1.34 -1.20 0.274 
Q3JLM3* Rhamnosyltransferase 2 
(RhlC)* 
1.00 0.43 NO NO -4.34 0.001 
A2RWE5 Rhamnosyltransferase 2 
(RhlC)* 
0.94 0.43 NO NO -4.34 0.001 
E1TAD4 Phosphoglucomutase/ 
phosphomannomutase (AlgC) 
0.45 0.62 0.97 0.54 0.68 0.360 
B4ECS6 dTDP-glucose 4,6-dehydratase 
(RmlB) 
NO 0.13 0.24 0.27 0.84 0.503 
H6TI92 dTDP-4-dehydrorhamnose-
3,5-epimerase (RmlC) 
1.13 NO 0.58 1.24 0.91 0.233 
Q2SYI1 dTDP-4-dehydrorhamnose 
reductase (RmlD)* 
1.22 0.60 1.10 1.52 2.73 0.030 
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Biosynthesis of RLs requires R-3-hydroxydecanoyl-ACP or -CoA lipid precursor 
produced from FAS II and/or β-oxidation pathways, respectively (64, 73, 74) and biosynthesis of 
dTDP-L-rhamnose sugar precursor. Once lipid and sugar precursor are produced, RhlABC 
mediates the formation of mono- or dirhamnolipids. Table 8Table 11 lists the relative 
abundance of the enzymes detected in the 4 treatments (A, B, C and D), the LogFC and P-value. 
These enzymes are responsible for RL biosynthesis. For example, the anabolic enzymes AlgC 
and RmlBCD involved in dTDP-L-rhamnose biosynthesis were detected in all treatments (Table 
11). RmlD catalyzes the final step from dTDP-4-keto-6-deoxy-L-mannose to dTDP-rhamnose 
and the LogFC was significantly up-regulated (p-value<0.05). RmlC was also up-regulated. Both 
RmlD and RmlC relative abundance suggests that synthesis of RL sugar precursors is not 
inhibited by OC. Additionally, the relative abundance of RmlC in treatment A and D suggest that 
the synthesis of dTDP rhamnose is delayed with DBT alone or in the treatment containing OC. 
Enzymes from FAS II and/or β-oxidation pathways were detected in the 4 treatments (A, 
B, C and D), indicating these pathways are active in C3. FabG is a key enzyme in R-3-
hydroxydecanoyl-ACP synthesis via FAS II pathway (73). The relative abundance of FabG was 
>1 in all treatments, but treatment B was slightly lower than treatments A, C and D. However, 
the LogFC was down-regulation. The preceding step catalyzed by FabF was up-regulated in 
treatment C. β-oxidation enzymes FadB and FadE were abundant in treatment C (Table 11). We 
are unsure which is the main pathway providing the lipid precursor for RL synthesis. The data 
suggest that both FAS II and β-oxidation pathways are involved in the synthesis of RL lipid 
precursor. However, it is uncertain which pathway dominates in providing the lipid precursor for 
RL synthesis. 
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RhlA produces HAA which is then utilized by RhlB for monorhamnolipid biosynthesis 
(88). RhlA (U1XYV8) was identified and the LogFC showed up-regulation. Agreeing with 
Hypothesis 3 glycerol induces lipid precursor supply for biosynthesis of RL biosurfactant. 
Regarding rhamnosyltransferases, two RhlB and RhlC were identified and contrary to the 
expectations their LogFC were down-regulated (Table 11). These proteins are involved in the 
direct formation of mono-(85, 86) and di-rhamnolipids (87), respectively.   
 
8.3.5. Identification of RL congeners secreted by C3  
A RL standard containing a mixture of Rha-Rha-C10-C10 and Rha-C10-C10 congeners was 
used for HPLC and MALDI-TOF/TOF method development and to identify RLs in experimental 
samples. The RL standard that was resuspended in methanol was purified through HPLC and 
analyzed via MALDI-TOF. Fractions F1, F2, and F3 were collected the results are shown in 
Figure 20. 
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Figure 20. Analysis of RL standard via HPLC and MALDI-TOF. Chromatograms of 
RL standard were shown. Fractions were collected at 4-5 (F1), 5-6 (F2) and 7-8 (F3) minutes. 
Standard with two RL congeners (M1 and M2) were found as Na
+ 
and K
+
 adducts in F1, F2 and 
F3 fractions. RL congener M1: Rha-C10- C10 and RL congener M2: Rha-Rha-C10- C10. 
 
Rha-C10-C10 (M1) and Rha-Rha-C10-C10 (M2) congeners were found in all 
chromatographic fractions analyzed, but F2 fraction contained higher amounts of as shown by 
the intensity axis in Figure 20. RL congeners formed Na
+
, K
+
 and rarely [M-H+ Na2]
+
 ions 
adducts. Congeners forming [M-H+ Na2]
+
 ions are not shown.  
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Figure 21. Dirhamnolipid Rha-Rha-C10-C10 fragmentation pattern spectrum. 
Spectrum was obtained with MALDI-TOF/TOF. Rha: rhamnose sugar. RL congeners formed 
Na
+
, K
+
 and rarely [M-H+ Na2]
+
 ions adducts. Lipid fragments (C10-C10 or C10) formed K
+
 
adducts. Rhamnose fragments (Rha-Rha or Rha) formed Na
+
 adducts. 
 
After RL peaks were assigned, full fragmentation of Rha-Rha-C10-C10, m/z 673.476 
corresponding to [M+Na]
+
 adduct ion was achieved via MALDI-TOF/TOF (Figure 21). In 
addition to RL congeners, lipid fragments (C10-C10 or C10) consistently formed K
+
 adduct ions 
and rhamnose sugar fragments (Rha-Rha or Rha) formed Na
+
 adduct ions. Glycolipid peaks 
formed mainly Na
+
 adduct ions, which were seen in tandem mass spectrometry (e.g. Rha-C10 + 
Na
+
). 
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A RL molecule consist in either 1 or 2 rhamnose sugars attached through an O-glycosidic 
bond to 1 or 2 β-hydroxy fatty acids, with the lipid portion linked by an ester bond (37). RLs are 
easily fragmented molecules. All potential fragments were observed in tandem MS. The 
expected and observed ions are described in Table 12. A lipid fragment minus two hydrogens 
was consistent in lipid fragment loss. For example, if a C10 (C10H20O2) fragment was lost, the 
mass loss was 170.1463, instead of 172.1463.  
 
Table 12. Rha-Rha-C10-C10 dirhamnolipid fragments. Molecular weight and expected 
adduct ions mass was calculated with Compass IsotopePattern. 
Fragment 
Molecular 
Formula 
Expected 
M+Na
+ 
Observed 
M+Na
+
 
Expected 
M+K
+
 
Observed 
M+K
+
 
Rha-Rha-C10-C10 C32H58O13 673.3769 673.336 689.3509 680.308 
Rha-Rha-C10 C32H40O11 503.2285 503.225   
Rha-C10-C10 C26H48O9 527.3190 527.291 543.2929 543.262 
C10-C10 C20H40O4   381.2703 381.189 
Rha-C10 C15H28O7 357.178 357.109   
Rha-Rha C12H22O9  333.027   
Rha C6H12O5 187.0576 187.0110   
C10 C10H20O2   211.1094 211.054 
 
RL congeners were eluted between 4 and 6 minutes (Figure 20). The sample 
chromatograms (Figure 22) aligned well with RL standard chromatograms (Figure 20). Two 
fractions named, F1 and F2 were collected from experimental samples with 0.5 mM DBT and 
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either 50 mM glycerol or not. Fractions from cultures treated with 2 mM of HEX or OC 
inhibitors were also collected and chromatograms are shown in Figure 22. 
 
Figure 22. RL separation in experimental samples. RLs were extracted at day 2 from 
cell free supernatant cultures.  C3 was cultivated with top row: 50 mM glycerol/0.5 mM DBT 
and 50 mM glycerol/0.5 mM DBT with HEX or OC inhibitor (2mM). Bottom row: 0.5 mM 
DBT and 0.5 mM DBT with HEX or OC inhibitor (2 mM). F1: fraction 1 collected at 4-5 min. 
F2: fraction 2 collected at 5-6 min. AU: arbitrary units. 
 
The peak intensity on the 50 mM glycerol chromatogram was approximately 10-fold 
higher than the peak on the 0 mM glycerol chromatogram, supporting the results showed in 
Figure 18. Glycerol induced an increase in RL production. It is noteworthy that multiple peaks 
occurred at the OC chromatograms.  
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Figure 23. (A) MALDI-TOF-MS of 4 RL congeners (M1, M2, M3 and M4) identified 
and (B) LC-Q-ToF-MS2 of Rha-C10-C10 (M1). MS1 spectrum of HPLC fraction 2 (F2) is 
shown in (A). RL congeners were identified with MALDI TOF. Rha: rhamnose sugar. RL 
congeners identified: Rha-C10-C10 (M1+Na
+
), Rha-Rha-C10-C10 (M2+Na
+
), Rha-Rha-C10-C12 
(M3+Na
+
), Rha-Rha-C10-C12 (M3+K
+
) and Rha-Rha-C12-C12 (M4+K
+
). Peaks from (A) were 
assigned with a 0.5 Da error mass.  
 
We assigned the most intense peaks to RL congeners. In 50 mM glycerol, C3 secreted the 
congeners Rha-C10-C10 (M1+Na
+
), Rha-Rha-C10-C10 (M2+Na
+
), Rha-Rha-C10-C12, which was 
identified in the sodium (M3+Na
+
) or potassium (M3+K
+
) adduct ion form and Rha-Rha-C12-C12 
(M4+Na
+
). Monorhamnolipid congener Rha-C12-C12 was identified in 0 mM glycerol and with 
HEX or OC inhibitors (either in 50 or 0 mM glycerol) but the data is not shown. Peaks M1 and 
M2 were confirmed with tandem mass spectrometry. The mass spectrum of Rha-C10-C10 is 
shown in Figure 23B. Loss of C10 acyl chain and rhamnose sugar fragments (Rha) were 
observed. 
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9. CHAPTER 5: DISCUSSION 
Polycyclic aromatic hydrocarbon (PAH) biodegradation on liquid cultures with single 
carbon source depends on bacterial strain, type of PAH and PAH concentration. Seo et al. 
showed that Arthrobacter sp. P1-1 and Sinorhizobium sp. C4 degrade less than 10% of 40 ppm 
phenanthrene at day 1, whereas Mycobacterium sp. JS19b1
T
 and Burkholderia sp. C3 degrade 
20-25% and 60-65%, respectively (63). Another study shows that Mycobacterium sp. strains czh-
101 and czh-3 degrade less than 20% and 100% of 100 ppm phenanthrene at day 7, respectively 
(111). C3 degrades 100% of 40 ppm naphthalene and phenanthrene at day 3 and 94% of 40 ppm 
DBT at day 7 (35). Our results indicate that C3 degrades 11-12% of 100 ppm at day 7. A 
decrease in DBT biodegradation efficiency in C3 at a higher DBT concentration might be related 
to its toxicity. PAHs hydrophobicity (lipophilic nature) and carcinogenicity influences their 
toxicity (1, 3, 31, 32).  
Co-substrate experiments with DBT and glycerol neither exhibit a carbon catabolite 
repression phenomenon nor an antagonistic effect, which has been reported for other co-substrate 
mixtures (32, 111, 112). Instead, a cometabolism effect was observed. It is noteworthy that the 
term cometabolism is used to describe either of the following molecular processes: (1) broad 
substrate specificity of catabolic enzymes; (2) imperfect coupling between enzyme specificity 
and gene regulation; (3) xenobiotic compounds metabolism of a consortium with mutual 
metabolic reliance and (4) co-substrate effects on the metabolism of a xenobiotic compound 
(113). The results indicated that biostimulation with glycerol supports C3 growth and induced 
molecular processes 2 and 4. Phn enzymes involved in phenanthrene degradation in C3 (35) 
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were detected in the 4 treatments analyzed. Phenanthrene is a 3-ring PAH highly similar to DBT. 
Dioxygenases broad specificity has been reported in the literature for degradation of biphenyl, 
2,4-dinitrotoluene and DBT (114–116). Phenanthrene and DBT crossed-over metabolic points in 
were proposed in Mycobacterium aromativorans JS199B1 (116). The protein profiling results 
(Table 6) indicated that DBT, phenanthrene and naphthalene crossed-over pathways in C3 and 
this was independent of glycerol supplementation. For phenanthrene and naphthalene 
degradation two sets of genes were reported (35). The results showed a third set of enzymes for 
DBT degradation (Table 6). This enzyme set is involved in DBT degradation through lateral 
dioxygenation pathway (Figure 10), previously showed in Burkholderia sp. DBT1 (59), currently 
known as Burkholderia fungorum DBT 1 (117).  
Glycerol supplementation induced the expression of proteins involved in PAHs 
degradation (Table 6) and changes in lower aromatic pathways, which was evidenced by up-
regulation of tautomerase (A0A0M3TVK8) a protein involved in cellular metabolism of 
aromatic compounds (GO:0006725), FMN-dependent NADH-azoreductase (A0A0D5V7V5), 
2,3-dihydroxy-2,3-dihydrophenylpropionate dehydrogenase (Q93NA6) and catechol-2,3- 
dioxygenase (Q9RB89). Cometabolites can supply energy to support bacterial growth and may 
also function to induce several catabolic enzymes for degradation of the non-growth substrate 
(32).  
Upon absorption, glycerol underwent immediate phosphorylation followed by conversion 
into dihydroxyacetone-3-phosphate by GlpD (A0A0D5VFY1) and thus entered glycolysis as D-
glyceraldehyde-3-phosphate (Figure 3). This supported cell growth and consequently enhanced 
DBT biodegradation. There is an association between chemical biodegradation enhancement and 
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increase in bacterial growth (40, 81). The experiments showed that cometabolism enhancement 
and C3 growth are dependent upon the glycerol to DBT molar ratio used and the incubation time. 
For example, at 0.1:1 and 100:1 glycerol to DBT molar ratio, the DBT biodegradation rate 
constant was enhanced by 1.6-fold and 18-fold, respectively. Meanwhile, a 7 day incubation time 
is necessary for C3 to biodegrade 100% of DBT at a 100:1 glycerol to DBT molar ratio and 10 
days to degrade 90-95% at a 10:1 molar ratio (Fig. 1, Table 1). Interestingly, at 1:1 glycerol to 
DBT molar ratio C3 degraded 92% of 0.5 mM DBT at day 10 but, at this glycerol concentration 
C3 growth remained at 0.05 OD600.  
Glycerol supplies into several metabolic pathways (Figure 3). In addition to glycolysis and 
gluconeogenesis, glycerol supply into lipid metabolic pathways in C3. The use of HEX and OC, 
inhibitors of β-oxidation and FAS II pathways (64, 65), was investigated at 2 and 5 mM 
concentrations. In cultures supplemented with glycerol alone, exponential growth phase was 
delayed in approximately 2 days. C3 reached 0.3 and 0.35 OD600 with HEX and OC, respectively. 
Generally, the C3 growth curve phases were similar with either 2 mM or 5 mM. However, when a 
DBT-glycerol mixture was supplemented, the C3 growth and DBT degradation were highly 
compromised. At the protein level, the relative abundance of GlpD (A0A0D5VFY1) in treatment 
D (with OC inhibitor) was lower than in treatments B and C, which could partially explain the 
suppressed C3 growth (Figure 11).  
Protein profiling revealed additional mechanisms that were affecting DBT degradation. 
Detection of cyclopropane-fatty-acyl-phospholipid synthase (A0A0M3TVX7) indicated cell 
membrane changes. Cyclopropane-fatty-acyl-phospholipid synthase mutants of Pseudomonas 
putida DOT-T1E were less resistant to toluene. The mutants contained decreased levels of 9,10-
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methyl hexadecanoic and 11,12-methyl octadecanoic acids in their membrane when compared to 
wild-type. These changes did not affect membrane fluidity. Organic solvents m-xylene, 
ethylbenzene and propylbenzene also decreased survival rate of DOT-T1E mutant strain (118). 
Cyclopropane-fatty-acyl-phospholipid are non-essential components of cell membranes that 
provided organic solvent tolerance (118). Toluene tolerance protein A0A0D5VI71 has a LogFC 
value of 1.40 (p-value = 0.062) and its relative abundance in treatment C was 1.38. DBT 
degradation may produce toluene metabolites toxic for C3. Significantly up-regulated proteins 
suggested that C3 secreted several metabolites that warrant further metabolomics studies. 
Proteomics and metabolomics studies were reported in C3 in response to carbaryl. They reported 
that the most prominent metabolic changes were associated with biosynthesis and metabolisms of 
amino acid, sugars, PHA, lipids and cofactors (104). 
Phasin proteins were abundant in all treatments. Phasins are analogs to oleosins and they 
associate to PHA granules. They determine the surface-to-volume ratio and prevent coalescence 
with other cell components (105). PHA granules are mainly described for carbon and energy 
storage when carbon supplied is not a limiting factor (105). York et al., reported that phasin 
accumulation was dependent on expression of PHA synthase in Ralstonia eutropha (119). 
Additionally, PHA synthase proteins involved in PHA biosynthesis were significantly 
upregulated (Table 8). Phasins were previously proposed as reporters of PHA production (119). 
C3 grown with glycerol accumulated intracellular PHA granules and this were produced by day 
2 and remained at day 7 (Figure 14). When C3 was grown in DBT alone granules were not 
observed at day 2, contrary to the regulation of phasin (A0A0N1KL01). Intracellular PHA 
granules were observed in a small number of cells at day 7. It is interesting that on a limited 
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carbon supply C3 favored PHA granule formation. HEX and OC at 2 mM inhibited granule 
formation only at day 2. In addition to carbon and energy storage, PHA granules may have other 
roles involved in DBT and xenobiotics degradation. It was proposed that Bacillus sp. CYR1 
produced high levels of PHA from phenol, naphthalene and 4-chlorphenol (120). Production of 
PHA was reported in C3 in response to carbaryl, NB and glucose, where, the lowest levels were 
measured with carbaryl, followed by NB and glucose (104). Di Martino et al., (77) indicated that 
PHA accumulation influences biosurfactant production. PHA mutant Pseudomonas sp. KA-08 
showed less surface tension reduction than wild type when cultured in PHA accumulating 
conditions. PHA production also affected outer membrane characteristics (77). Additionally, a 
clear separation between the cell outer membrane and DBT was observed in the TEM images 
suggesting possible exopolysaccharide secretion or a type of chemical interaction (e.g. ionic, 
hydrophobic); however, additional experiments are required for further conclusions.  
PAH hydrophobicity and octane/water coefficient increases with their molecular weight 
(3, 31). Bioavailability of PAHs of interest is a main limitation for PAH biodegradation in a 
bioremediation site (31). It has been observed that biostimulation with biosurfactant exogenously 
added or endogenously produced can enhance bioremediation of hydrophobic chemicals through 
an increase in bioavailability (41, 43, 80, 121). However, contradicting results have also been 
reported (24, 41). Our results demonstrated that DBT cometabolism associated with increased 
PHA production and RL biosynthesis and secretion. Bioavailability of DBT to C3 is a first 
requirement for its biodegradation. DBT is a hydrophobic compound with a water solubility 
coefficient of 7.9 µM and an octanol-water portioning coefficient of 4.44 (12). Foam formation 
and apparent DBT solubilization were observed after 12 hours of incubation during 
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cometabolism experiments. Glycerol is a good carbon source for RL production in Pseudomonas 
species (37). The lipid precursor component of the RL molecule is produced in pathways 
supplied by glycerol (37, 64, 66). Identification of the rhlABC genes supported the possibility of 
RL biosynthesis in C3 (Figure 16, Table 9). In Burkholderia species, the rhlABC genes reside in 
the same gene cluster which is responsible for higher biosynthesis of dirhamnolipids over 
monorhamnolipids (37, 66, 67, 122). The presence of RLs affects DBT biodegradation at early 
stages of incubation which is supported by the surface tension decrease at day 1 (Figure 18B) 
and the RL secretion levels quantified with the orcinol assay (Figure 18,A) as well as effects of 
RL biosynthesis inhibition by HEX and OC on DBT biodegradation (Figure 19). Gutierrez et al. 
showed that inhibition of RhlA and PhaG enzymes in FAS II pathway by bromoalkanoic acids 
suppresses production of RLs and PHA in Pseudomonas species and this inhibition was 
dependent on the bromoalkanoic acid used (HEX or OC) (65). This is the first study that utilizes 
HEX and OC inhibitor in a Burkholderia species to investigate their effect of PHA and RL 
production.  
Abdel-Mawgoud et al. demonstrated the direct involvement of β-oxidation via a enoyl-
CoA hydratase/isomerase (RhlYZ) (64). FadE (from β-oxidation) and FabF and FabZ (from FAS 
II) were upregulated with glycerol, indicating that supplementation with glycerol affected both of 
these pathways. It is uncertain whether one or both lipid pathways (β-oxidation or FAS II) 
provided the lipid precursors for RL biosynthesis in C3. Both lipid pathways were activated in 
C3 (Table 8). RL biosynthesis was active in all treatments, which was supported by RhlABC 
enzyme and RL congeners identification. monorhamnolipid Rha-C10-C10 and dirhamnolipids 
Rha-Rha-C10-C10, Rha-Rha-C10-C12 and Rha-Rha-C12-C12 were identified in 50 mM glycerol and 
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0.5 mM DBT (Figure 23), whereas, only Rha-C12-C12 monorhamnolipid congener was identified 
in cultures without glycerol or with HEX or OC inhibitors.  
The levels of RLs detected in the extracts of biodegradation cultures associates well with 
the amount of DBT biodegraded. The cometabolism results show up to an 18-fold increase in 
DBT biodegradation and a tripling in RL secretion. Inhibition of RL biosynthesis suppresses 
DBT biodegradation up to 8-fold. Fortification of RLs into cultures without glycerol results in a 
1.8-fold increase of DBT biodegradation which further confirm our findings.  
The amphipathic properties of RLs suggest multiple functions for RL producers and PAH 
degraders. Some of these roles are related with hydrophobic chemical solubilization, chemical 
uptake and biological assimilation (37, 41). RL involvement in cell transport could also increase 
the biodegradation of hydrophobic chemicals (123). The dual functions of RL production and 
PAH degradation may confer to the microorganism an evolutional adaptation to survive in 
environmental conditions where hydrophobic chemicals are scarce. Bioremediation studies in the 
site show that microbial abundance is associated with biorespiration (23, 121) and thus chemical 
biodegradation (24).  
Two main mechanisms are proposed for RL interactions with hydrophobic pollutants. 
One involves chemical solubilization via RL micelle uptake (31), the second, affects cell 
membrane hydrophobicity for cell attachment and biofilm formation (37, 41). The cometabolism 
results show up to an 18-fold increase in DBT biodegradation and a tripling in RL secretion. 
However, the amounts of RLs secreted, especially, in those cultures without glycerol were below 
the CMC. Above or at the CMC the surface tension of RL is 30 mN/m (37). The proteome 
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profiling results showed that C3 modified its cell membrane with glycerol supplementation. 
Based on our results, we proposed that the second mechanism is taking place in C3. Glycerol 
supported C3 growth and affected RL production and several other metabolic pathways which 
resulted in enhanced cometabolism of DBT. 
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10. CHAPTER 6: CONCLUSION AND FUTURE DIRECTIONS 
Glycerol induced DBT cometabolism via several mechanisms. The most apparent one 
was related to an increase in C3 biomass. Extensive literature review, observation of the 
biodegradation cultures, and analysis and interpretation of preliminary data lead to protein 
profiling, PHA granule and RL identification and characterization experiments. The results 
indicated that glycerol induced the expression of proteins related in xenobiotic degradation 
(phenanthrene, naphthalene and DBT) and changes in lower aromatic metabolic pathways. Broad 
dioxygenase specificity was also evidenced but this was independent of glycerol 
supplementation. Metabolomics analysis of DBT metabolites in addition to protein profiling 
would allow depicting a full DBT catabolic pathway and this will probably varied dependent 
upon the co-substrates used. DBT as a model chemical showed great potential to further 
investigate cometabolism of other PAHs. It is important to emphasize that metabolic capability is 
the first requirement for a successful bioremediation strategy and thus should be considered for 
the selection of a proper strain or microbial consortium.  
Lipid metabolism, PHA production, granule formation and RL biosynthesis and secretion 
were all metabolic process affected by glycerol and were shown to affect DBT degradation. C3 
secreted 3 dirhamnolipid congeners when supplemented with glycerol as opposed to 1 
monorhamnolipid with DBT alone or when cells were treated with HEX or OC inhibitor. 
However, culturing conditions made difficult the purification and characterization process and a 
tandem mass spectrum of the congeners was not obtained. Characterization and quantification of 
RLs secreted by C3 from different carbon sources are required to optimize RL production by C3. 
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The data also suggested changes in membrane fatty acid composition and possible 
exopolysaccharides secretion. Additional experiments would help evidencing these changes in 
response to different culturing conditions.  
This dissertation utilized glycerol as a co-substrate for DBT cometabolism and RL 
production. The chemical composition of the crude glycerol fraction from biodiesel production 
varies greatly. Glycerol in this fraction ranges between 38-96%. Crude glycerol fractions also 
contain methanol and ash (68). The use of crude glycerol should be investigated for biosurfactant 
production and DBT degradation. Utilization of a direct supply of crude glycerol from biodiesel 
production would be attractive to the biodiesel industry to make biodiesel production more cost-
effective.  
The studies suggested that utilization of glycerol could potentially lead to effectively 
biodegrade PAHs in contaminated soil. This cometabolism strategy could be applied in 
combination with bioaugmentation of a suitable microbial consortium (24, 121, 124). Glycerol 
may trigger a superior response in a bacterial population with a mixture of PAH degraders and 
RL producers, or both (38–41, 81). An initial analysis of the bacterial population and cellular 
respiration and PAH biodegradation monitoring over time would be required for a proper 
assessment of this strategy (23, 24, 121). 
Biosurfactants have been used in many different fields (125) and have a promising  
potential in environmental clean-up of PAHs (31). Patowary et al., (126) suggested that the 
presence of biosurfactant producers in an optimal bacterial consortium reduced the adaption time 
of hydrocarbon degrading microorganisms. They reported that decreased in total petroleum 
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hydrocarbon content correlated with surface tension reduction (126). A RL ratio of 150 mg per 
Kg of soil was reported for enhanced increase in microbial activity. They also suggested RL 
introduction to the soil every 30 days (24). It has been reported that the time that soil particles 
were exposed to diesel influenced the level of adsorption into the soil. This influence was related 
to the soil organic matter content. As to which a higher biodegradation efficiency was achieved 
with lower organic matter content (24). However, direct studies on the interaction of soil 
particles with PAHs and the effects of biosurfactants are scarce and required further 
investigation.  
Glycerol greatly enhanced biodegradation of 0.5 mM DBT by C3. Our studies revealed 
that complex metabolic networks and cellular mechanisms are induced by glycerol. To our 
knowledge this is the first report linking these pathways to the biodegradation of DBT. The 
factors described in this study probably enhance the degradation of heavier PAHs which are 
more hydrophobic and recalcitrant to degradation. 
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12. ANNEXED 
Table 13. Full description of significantly abundant proteins (p-value < 0.05). 
Proteins are shown in alphabetic order. Treatments were: A, 0.5 mM DBT; B, 50 mM glycerol; 
C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM OC. Proteins 
were extracted at day 2. Three biological replicates were analyzed in each treatment. Mean 
normalized value is shown in each treatment. The LogFC represents the glycerol*DBT 
interaction term. 
  Relative abundance by 
treatment 
  
UniProt ID Protein description A B C D LogFC P-value 
Q93NA6 2,3-dihydroxy-2,3-
dihydrophenylpropionate 
dehydrogenase  
1.08 0.36 1.59 1.52 1.70 0.007 
A0A0M4PT16 2-dehydropantoate 2-reductase  0.00 0.00 1.07 0.00 3.36 0.005 
B1JU41 50S ribosomal protein L15  0.99 0.89 1.05 1.24 1.20 0.044 
B5WTF5 50S ribosomal protein L15  0.99 0.89 1.05 1.24 1.20 0.044 
A0A0D5V6G6 50S ribosomal protein L7/L12  1.22 0.75 0.96 1.42 1.24 0.019 
A0A0D5VNH8 6-phosphogluconate dehydrogenase, 
decarboxylating  
0.00 0.94 0.44 0.00 -2.03 0.005 
A0A0D5V8G0 ABC transporter family protein  1.39 0.18 0.57 0.27 -1.85 0.024 
A0A0D5VCE5 ABC transporter family protein  1.13 0.98 0.44 0.27 -2.04 0.006 
A0A088TW83 ABC transporter, solute-binding 
protein  
0.00 0.94 0.49 0.00 -2.11 0.041 
A0A0D5VDU6 Acetaldehyde dehydrogenase 2  0.00 0.60 1.53 0.00 2.85 0.000 
A0A0D5V7J1 Acetyl-coenzyme A synthetase  0.00 0.91 0.00 0.00 -3.66 0.002 
A0A0M3TWC5 Acetyl-coenzyme A synthetase  0.00 0.91 0.00 0.00 -3.66 0.002 
A0A0D5VDE2 Acetylornithine aminotransferase  1.68 1.57 0.96 1.52 -1.55 0.010 
A0A0D5VBP8 Acetyltransferase component of 
pyruvate dehydrogenase complex  
1.49 1.22 0.63 0.84 -2.19 0.003 
C4AQ27 Acyl-CoA synthase  0.99 0.18 0.20 0.00 -3.33 0.014 
A0A0D5VM16 Aldo/keto reductase family protein  0.00 1.20 0.20 0.00 -2.41 0.017 
A0A0D5VJE9 Alpha amylase, catalytic domain 
protein  
0.00 1.38 0.69 0.00 -4.61 0.000 
A0A0D5VMD4 Amino acid adenylation domain protein  0.00 2.57 0.00 0.00 -6.41 0.000 
A0A0D5V9V2 Aminomethyltransferase folate-binding 
domain protein  
0.00 1.07 0.00 0.00 -3.69 0.002 
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Table 13 (continued). Full description of significantly abundant proteins (p-value < 
0.05). Proteins are shown in alphabetic order. Treatments were: A, 0.5 mM DBT; B, 50 mM 
glycerol; C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM 
OC. Proteins were extracted at day 2. Three biological replicates were analyzed in each 
treatment. Mean normalized value is shown in each treatment. The LogFC represents the 
glycerol*DBT interaction term. 
  Relative abundance by 
treatment 
  
UniProt ID Description A B C D LogFC P-value 
A0A0D5VEW3 Aminomethyltransferase  0.64 1.20 0.57 0.53 -1.72 0.021 
A0A0D5VF93 Aminopeptidase N  0.00 1.37 0.46 0.00 -1.86 0.036 
A0A0D5V5Y2 Aminotransferase class I and II family 
protein  
1.32 1.23 0.83 1.10 -1.70 0.005 
A0A0D5VLM9 Aminotransferase class-III family 
protein  
0.72 1.34 0.00 0.00 -4.75 0.000 
A0A0D5VB61 Arginine-tRNA ligase  0.62 1.48 0.20 0.54 -2.30 0.011 
R9W162 Aromatic-ring-hydroxylating 
dioxygenase  
1.73 0.42 1.58 2.17 1.39 0.033 
B2T171 Aspartate 1-decarboxylase  0.58 0.00 0.00 1.34 2.38 0.027 
A0A0D5VFE6 Aspartate-tRNA ligase  0.00 1.07 0.00 0.00 -2.65 0.011 
A0A0M4NYD7 ATP:cob(I)alamin adenosyltransferase  1.22 0.23 1.60 1.55 1.99 0.001 
A0A0D5VJR3 Bacterial extracellular solute-binding 
family protein  
0.00 0.13 0.91 1.20 1.92 0.045 
A0A0D5VFF5 Bacterial extracellular solute-binding 
family protein  
1.39 1.64 1.36 1.13 -1.00 0.047 
A0A0N0IDK4 Beta-eliminating lyase family protein  0.00 1.02 0.00 0.00 -3.41 0.006 
A0A0D5VBD8 Carbohydrate-binding family V/XII  0.00 1.00 0.62 0.00 -2.41 0.017 
A0A0D5VFX6 Chaperone protein DnaK  1.40 0.98 0.24 1.45 -1.20 0.022 
A0A0D5V7V8 Chaperone protein HtpG  1.80 0.88 0.00 1.34 -2.21 0.002 
A0A0D5VDT3 Chaperone SurA  2.01 1.68 2.33 2.21 1.18 0.016 
Q13SY2 Chemotaxis response regulator protein-
glutamate methylesterase  
0.00 0.93 0.20 0.00 -2.11 0.040 
A0A0D5VBP4 Chromosome partition protein Smc  0.85 1.16 0.42 0.00 -2.36 0.001 
A0A0D5V8E3 CTP synthase  0.00 1.03 0.20 0.27 -3.29 0.000 
O86041 Cupin  1.23 1.52 1.28 0.27 -1.55 0.008 
A0A0D5VI43 Cyclic peptide transporter family protein  0.00 1.19 0.69 0.00 -1.80 0.021 
A0A0D5VJG9 D-alanine-poly(Phosphoribitol) ligase, 
subunit 1  
0.00 2.92 0.00 0.00 -6.71 0.000 
G5L3J5 Dihydrodipicolinate synthase/N-
acetylneuraminate lyase  
2.42 0.46 2.42 2.34 2.45 0.000 
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Table 13 (continued). Full description of significantly abundant proteins (p-value < 
0.05). Proteins are shown in alphabetic order. Treatments were: A, 0.5 mM DBT; B, 50 mM 
glycerol; C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM 
OC. Proteins were extracted at day 2. Three biological replicates were analyzed in each 
treatment. Mean normalized value is shown in each treatment. The LogFC represents the 
glycerol*DBT interaction term. 
  Relative treatment by 
abundance 
  
UniProt ID Description A B C D LogFC P-value 
A0A0D5VK03 Dihydroxy-acid dehydratase  0.23 1.16 0.63 0.27 -1.80 0.027 
A0A0D5VH17 DNA polymerase I  0.00 0.94 0.20 0.00 -3.56 0.003 
A0A0D5VD44 DNA-directed RNA polymerase 
subunit beta  
0.45 1.16 0.25 0.80 -2.15 0.004 
A0A0D5VAX2 DNA-directed RNA polymerase 
subunit beta'  
0.85 1.26 0.97 0.68 -4.00 0.000 
A0A0M5LFU7 DSBA oxidoreductase  1.82 0.00 0.00 0.41 -3.31 0.001 
A0A0D5VBB3 Efflux pump membrane family protein  0.00 0.00 1.54 0.27 4.26 0.000 
A0A0D5VCE6 Elongation factor G  0.49 1.16 0.00 0.00 -5.01 0.000 
A0A0D5VEA5 Endoribonuclease L-PSP family 
protein  
0.26 0.23 0.20 1.10 2.65 0.039 
B2T4A8 Enoyl-[ACP] reductase [NADH]  0.00 1.07 0.00 0.00 -4.07 0.000 
A0A0D5V781 Enoyl-CoA hydratase/isomerase family 
protein  
0.00 1.11 0.44 0.00 -2.11 0.013 
A0A0M4P2D0 Extracellular solute-binding protein 
family 5  
0.00 0.30 0.96 0.00 1.86 0.044 
A0A0D5VBT1 Flagellar motor switch protein FliG  0.94 0.00 0.00 0.00 -3.23 0.006 
Q93CN7 Putative monoxygenase alpha subunit 2.02 1.62 2.02 1.87 1.89 0.007 
A0A0D5VB09 Flavohemoprotein  1.64 0.00 0.00 1.34 -1.89 0.042 
A0A0D5V7V5 FMN-dependent NADH-azoreductase  0.45 0.18 1.35 1.77 5.75 0.000 
A0A0D5VLU1 Glucose-6-phosphate 1-dehydrogenase  0.23 1.01 0.33 0.00 -2.72 0.004 
A0A0D5VBW3 Glutamate synthase (Ferredoxin)  0.00 1.02 0.00 0.27 -4.26 0.000 
Q13V40 Glutamate-1-semialdehyde 2,1-
aminomutase  
0.00 0.93 0.00 0.00 -2.70 0.037 
A0A0D5V9H7 Glutamine-fructose-6-phosphate 
aminotransferase [isomerizing]  
0.00 1.20 0.00 0.00 -3.36 0.007 
A0A0D5VFY1 Glycerol-3-phosphate dehydrogenase  0.00 1.07 1.94 0.53 1.76 0.003 
A0A0D5VMH1 Glycine betaine/L-proline transport 
ATP binding subunit  
1.57 0.31 0.00 0.00 -5.23 0.000 
Q13SR6 Glycine dehydrogenase 
(decarboxylating)  
1.02 1.22 0.33 1.10 -1.34 0.029 
117 
 
Table 13 (continued). Full description of significantly abundant proteins (p-value < 
0.05). Proteins are shown in alphabetic order. Treatments were: A, 0.5 mM DBT; B, 50 mM 
glycerol; C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM 
OC. Proteins were extracted at day 2. Three biological replicates were analyzed in each 
treatment. Mean normalized value is shown in each treatment. The LogFC represents the 
glycerol*DBT interaction term. 
  Relative abundance by 
treatment 
  
UniProt ID Description A B C D LogFC P-value 
A0A0D5VAC2 Glycine-tRNA ligase beta subunit  1.30 1.79 0.73 0.27 -2.09 0.001 
A0A0D5VCV1 Glycolate oxidase, subunit GlcD  0.00 1.23 0.20 0.00 -2.52 0.011 
A0A0D5V8X4 Heme ABC exporter, ATP-binding 
protein CcmA  
1.40 0.60 0.00 0.00 -4.99 0.000 
A0A0D5V647 Heme ABC exporter, ATP-binding 
protein CcmA  
0.26 1.16 0.00 0.00 -4.01 0.001 
A0A0D5VD28 Hsp70 family protein  1.36 0.66 0.00 0.27 -3.67 0.001 
G5L3J5 Hydratase-aldolase  1.98 1.27 2.33 2.40 1.97 0.000 
A0A0D5VIM7 Intracellular multiplication and 
macrophage-killing family protein  
0.36 1.12 0.20 0.00 -3.18 0.000 
A0A0D5VJ60 Isocitrate dehydrogenase, NADP-
dependent  
0.49 1.89 0.25 0.00 -3.64 0.000 
A0A0D5VAW4 Isocitrate lyase  0.26 1.35 0.69 0.00 -2.14 0.002 
A0A0D5VEQ0 Isoleucine-tRNA ligase  0.00 1.23 0.33 0.00 -1.95 0.026 
A0A0N0ZGK7 Lactoylglutathione lyase  0.58 0.48 0.42 1.24 1.52 0.046 
A0A0D5VBP9 LPS export ABC transporter ATP 
binding protein  
1.40 0.62 0.33 0.27 -1.90 0.019 
A0A0D5VBW4 LTXXQ motif family protein  0.72 0.99 1.43 1.20 1.50 0.023 
A0A0D5V5U8 Malic enzyme, NAD binding domain 
protein  
0.23 1.39 1.10 0.00 -1.11 0.036 
A0A0D5V6I0 Malic enzyme, NAD binding domain 
protein  
1.36 1.50 0.86 1.30 -1.92 0.001 
A0A0D5V9M1 NAD dependent 
epimerase/dehydratase family protein  
0.45 1.07 0.20 0.53 -4.44 0.000 
A0A0D5V8Z7 NADH-quinone oxidoreductase  1.02 1.29 0.00 0.00 -4.96 0.000 
A0A0M4NP56 Naphthalene 1,2-dioxygenase  1.68 0.23 1.66 1.76 1.26 0.044 
A0A0D5VK45 Nitrate reductase, alpha subunit  2.55 0.42 0.25 2.01 -2.34 0.001 
A0A0D5VM92 Nitrate reductase, beta subunit  2.05 0.13 0.00 1.34 -3.43 0.000 
A0A0D5VE52 NlpB/DapX lipofamily protein  0.58 1.10 0.49 0.00 -2.68 0.007 
A0A0D5VDA6 OsmC-like family protein  0.00 0.13 0.83 1.10 2.62 0.016 
A0A0D5VD61 Outer membrane/peptidoglycan-
associated (Lipo)protein  
2.06 1.62 1.46 2.02 -1.45 0.005 
118 
 
Table 13 (continued). Full description of significantly abundant proteins (p-value < 
0.05). Proteins are shown in alphabetic order. Treatments were: A, 0.5 mM DBT; B, 50 mM 
glycerol; C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM 
OC. Proteins were extracted at day 2. Three biological replicates were analyzed in each 
treatment. Mean normalized value is shown in each treatment. The LogFC represents the 
glycerol*DBT interaction term. 
  Relative abundance by 
treatment 
  
UniProt ID Description A B C D LogFC P-value 
Q143E5 Outer-membrane lipoprotein carrier 
protein  
0.64 1.06 0.96 0.26 -1.86 0.040 
A0A0D5VG00 Oxoglutarate dehydrogenase (Succinyl-
transferring), E1 component  
1.49 1.15 0.42 1.20 -2.29 0.000 
C7DQY6 PAH dioxygenase small subunit  1.45 1.40 1.12 0.92 -1.28 0.036 
A0A0D5VLZ1 Peptidase M1 family protein  0.00 1.38 0.25 0.00 -2.50 0.012 
A0A0D5VEM2 Peptidase M3 family protein  0.64 1.13 0.00 0.69 -2.69 0.003 
A0A0D5VMS9 Peptidyl-prolyl cis-trans isomerase  0.49 0.85 1.05 1.10 2.41 0.003 
Q13X57 Peptidyl-prolyl cis-trans isomerase  1.02 1.15 1.60 1.63 1.09 0.037 
A0A0D5VH07 Peroxiredoxin, Ohr subfamily protein  0.23 0.50 0.96 1.10 2.44 0.008 
A0A0N1KL01 Phasin family domain protein  2.03 2.13 2.26 1.96 -1.34 0.005 
A0A0D5VCV0 Phosphatidylethanolamine-binding 
family protein  
0.23 0.66 0.96 1.24 2.01 0.030 
A0A0D5V9F1 Phosphoenolpyruvate carboxylase  0.00 1.81 1.17 0.00 -1.27 0.042 
A0A0D5VDY9 Phosphoenolpyruvate synthase  0.59 1.16 0.00 0.53 -3.14 0.000 
A0A0D5VER0 Phosphoenolpyruvate-
proteinphosphotransferase  
0.45 0.71 0.00 0.00 -3.32 0.009 
B2SXE3 Phosphoenolpyruvate-protein 
phosphotransferase  
0.36 0.93 0.00 0.00 -3.90 0.001 
A0A0D5V8K8 Phosphoglycerate kinase  0.00 1.25 0.82 0.27 -1.64 0.019 
A0A0N0IEG4 Phosphomethylpyrimidine synthase  0.49 0.93 0.00 0.00 -4.36 0.000 
A0A0D5VDM4 Phosphoribosyl transferase domain 
protein  
0.72 0.41 1.19 1.42 1.92 0.012 
A0A0D5V925 Phosphoribosylformylglycinamidine 
synthase  
0.23 1.80 0.00 0.00 -5.42 0.000 
A0A0Q5H1G7 Poly(R)-hydroxyalkanoic acid synthase  0.23 0.00 0.83 0.80 2.77 0.011 
W6X074 Poly(R)-hydroxyalkanoic acid 
synthase, class I  
0.41 0.00 0.54 0.95 2.09 0.043 
A9BZX2 Poly(R)-hydroxyalkanoic acid 
synthase, class I  
0.00 0.13 0.83 0.80 2.51 0.017 
A0A0N7JU12 Polyhydroxyalkanoic acid synthase  1.19 0.00 0.00 0.00 -3.75 0.007 
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Table 13 (continued). Full description of significantly abundant proteins (p-value < 
0.05). Proteins are shown in alphabetic order. Treatments were: A, 0.5 mM DBT; B, 50 mM 
glycerol; C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM 
OC. Proteins were extracted at day 2. Three biological replicates were analyzed in each 
treatment. Mean normalized value is shown in each treatment. The LogFC represents the 
glycerol*DBT interaction term. 
  Relative abundance by 
treatment 
  
UniProt ID Description A B C D LogFC P-value 
A0A0D5VFS8 Protein-export protein SecB  0.99 0.60 0.33 1.30 1.96 0.012 
Q93CP1 Putative isomerase  1.93 0.00 0.00 0.41 -3.50 0.000 
Q93CP1 Putative isomerase  1.09 0.90 0.25 0.27 -2.50 0.006 
A0A0D5VIB5 Putative NADH 
dehydrogenase/NAD(P)H 
nitroreductase 
0.59 1.37 1.98 2.02 1.29 0.017 
A0A0M4P147 Putative serine protein kinase, PrkA  0.00 1.44 0.25 0.00 -3.27 0.000 
A0A0N0IFY8 Putative translation initiation 
inhibitor, yjgF family  
1.42 0.60 0.63 0.95 -1.96 0.021 
A0A0D5VE80 Pyruvate dehydrogenase E1 
component  
1.82 1.42 1.05 0.80 -1.56 0.003 
A0A0D5V9F4 Pyruvate kinase  0.23 1.32 0.96 0.27 -1.78 0.011 
Q3JLM3 Rhamnosyltransferase 2  1.00 0.43 0.00 0.00 -4.34 0.001 
A2RWE5 Rhamnosyltransferase II  0.94 0.43 0.00 0.00 -4.34 0.001 
A0A0D5V939 Ribonuclease E  0.00 1.12 0.25 0.00 -2.45 0.002 
A0A0D5VDW9 Ribose-phosphate pyrophosphokinase  1.36 0.62 0.46 0.53 -2.24 0.040 
A0A0D5VLP3 RNA polymerase sigma factor RpoD  0.00 1.01 0.33 0.00 -2.56 0.002 
A0A0D5VEZ5 RNA polymerase-binding 
transcription factor DksA  
0.72 0.62 1.10 0.95 1.11 0.048 
A0A0D5VFS0 RND transporter, 
hydrophobe/amphiphile efflux-1 
family protein  
1.17 0.61 0.00 0.69 -3.95 0.000 
A0A0D5VCJ1 S1 RNA binding domain protein  0.49 1.00 0.00 0.69 -3.38 0.001 
A0A0D5VDD8 Serine hydroxymethyltransferase  0.00 0.93 1.10 0.00 -1.70 0.002 
A0A0D5V9T1 Short chain dehydrogenase family 
protein  
0.00 1.13 0.20 0.00 -2.29 0.024 
A0A0D5VPP2 Short chain dehydrogenase family 
protein  
0.00 0.00 1.75 0.26 4.66 0.000 
A0A0D5VG50 Signal transducing histidine kinase, 
homodimeric domain protein  
1.32 0.88 0.79 0.54 -1.16 0.038 
A0A0D5VFC1 Soluble lytic murein transglycosylase 
L domain protein  
0.45 1.23 0.63 0.00 -2.56 0.011 
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Table 13 (continued). Full description of significantly abundant proteins (p-value < 
0.05). Proteins are shown in alphabetic order. Treatments were: A, 0.5 mM DBT; B, 50 mM 
glycerol; C, 50 mM glycerol and 0.5 mM DBT; D, 50 mM glycerol, 0.5 mM DBT and 2 mM 
OC. Proteins were extracted at day 2. Three biological replicates were analyzed in each 
treatment. Mean normalized value is shown in each treatment. The LogFC represents the 
glycerol*DBT interaction term. 
  Relative abundance by 
treatment 
  
UniProt ID Description A B C D LogFC P-value 
A0A0D5V720 Succinyl-CoA ligase [ADP-forming] 
subunit beta  
1.63 1.22 1.05 1.24 -1.08 0.039 
A0A0D5V735 Sulfate ABC transporter, sulfate-
binding family protein  
0.23 0.84 1.67 1.00 1.31 0.016 
A0A0D5VNY2 Sulfurtransferase  0.00 0.93 0.00 0.00 -3.21 0.011 
A0A0M3TVK8 Tautomerase  0.00 0.00 0.44 0.95 3.74 0.004 
A0A0M3TVE7 Threonine synthase  0.00 0.92 0.00 0.00 -3.83 0.001 
A0A0D5V9J4 Threonine--tRNA ligase  0.62 1.55 0.49 0.26 -2.70 0.010 
A0A0D5V7D0 Thymidylate kinase  0.99 0.89 0.33 0.27 -1.74 0.036 
A0A0D5VMA4 TonB dependent receptor family 
protein  
2.36 0.00 0.00 0.54 -4.91 0.000 
A0A0D5VNE5 TonB-dependent siderophore receptor 
family protein  
0.00 1.09 0.37 0.00 -3.57 0.003 
A0A0D5VMB8 TonB-dependent siderophore receptor 
family protein  
1.38 2.24 1.18 0.52 -2.69 0.000 
A0A0D5VGP4 TonB-dependent siderophore receptor 
family protein  
0.00 2.02 1.43 0.27 -1.23 0.039 
A0A0N0ZGN2 Transketolase  1.71 1.44 0.73 1.28 -1.93 0.001 
A0A0D5VJ16 Type VI secretion ATPase, ClpV1 
family  
0.00 1.93 0.73 0.00 -2.07 0.002 
A0A0D5VDN9 Uncharacterized protein  0.00 0.99 0.44 0.00 -2.01 0.005 
A0A0N0IFW9 Uncharacterized protein  1.32 0.13 0.46 0.27 -4.72 0.000 
A0A0M4P0G0 Uncharacterized protein  0.81 1.02 1.06 1.10 -2.15 0.009 
A0A0D5VEE7 Uncharacterized protein  0.00 0.96 0.20 0.00 -3.96 0.001 
A0A0D5VGK4 Uncharacterized protein  0.23 1.07 0.69 0.00 -2.00 0.010 
A0A0D5VPU9 Uncharacterized protein  0.45 1.86 2.05 0.41 1.61 0.006 
A0A0D5VNT3 Uncharacterized protein  0.23 0.23 0.20 1.30 2.46 0.014 
A0A0D5VIL6 Uncharacterized protein  0.00 1.01 0.00 0.00 -3.41 0.006 
A0A0M3TVK2 Uncharacterized protein  0.23 0.36 1.51 1.00 2.12 0.001 
A0A0D5VCB1 YceI-like domain protein  0.96 1.39 0.91 0.80 -1.75 0.024 
 
